表紙
市場調查報告書
商品編碼
910133

新的細胞分選·分離技術的全球市場 (2019-2030年):聲電泳·浮力·介電泳·磁導·微流體·光電子產品·無跡親和性·其他

Novel Cell Sorting and Separation Market: Focus on Acoustophoresis, Buoyancy, Dielectrophoresis, Magnetophoretics, Microfluidics, Optoelectronics, Traceless Affinity and Other Technologies, 2019-2030

出版日期: | 出版商: Roots Analysis | 英文 519 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供新的細胞分選·分離技術的市場調查,彙整細胞分選·分離技術類型和概要,競爭環境與主要企業的簡介,產品類型·最終用途/用途·技術·細胞類型·地區/主要國家等各種區分趨勢與市場規模的變化與預測,專利資料,專家的各種見解等資料。

第1章 序文

第2章 摘要整理

第3章 簡介

  • 背景
  • 簡介:細胞分選·分離
  • 新的細胞分選·分離技術
    • 浮力主動式化區分
    • 微流體的區分
      • 微流體的主動式分選
      • 微流體的被動式分選
    • 其他細胞分選·分離技術
  • 新的細胞分選·分離技術的主要用途
    • 臨床研究
    • 生物學的診斷
    • 細胞治療
  • 成長推進因素·障礙
  • 近幾年的發展·這次趨勢

第4章 目前市場環境

第5章 競爭分析

第6章 簡介:新型細胞分選儀·分離技術的主要企業

  • NanoCellect Biomedical
  • Innovative Biochips
  • Cesca Therapeutics
  • Fluidigm
  • LumaCyte
  • Union Biometrica
  • LevitasBio
  • RareCyteR
  • Cytonome
  • Namocell

第7章 簡介:新的消耗品·離析套件的主要企業

  • STEMCELL Technologies
  • Akadeum Life Sciences
  • QIAGEN
  • RareCyteR
  • ScreenCell

第8章 專利分析

第9章 出版物分析

第10章 聯盟·合作

第11章 資金提供·投資分析

第12章 需求分析

  • 本章概要
  • 需求預測
    • 最終用途·各用途
      • 研究·調查
      • 循環腫瘤細胞檢測
      • 體外受精
      • 非侵入性產前診斷
      • 細胞治療
    • 各地區

第13章 市場預測

  • 本章概要
  • 整體市場預測
    • 各提供類型
      • 細胞分選儀
      • 消耗品·離析套件
    • 最終用途·各用途
      • 研究·調查
      • 循環腫瘤細胞檢測
      • 體外受精
      • 非侵襲靜性產前診斷
      • 細胞治療
    • 各細胞區分技術
      • 浮力活性
      • 磁浮
      • 微流體
      • 光電子產品
      • 其他
    • 各細胞類型
      • 動物細胞
      • 癌症細胞
      • 免疫細胞
      • 微生物細胞
      • 紅血球細胞/ 血小板
      • 幹細胞
    • 各地區
      • 北美
      • 歐洲
      • 亞太地區

第14章 專家的見解

第15章 總論

第16章 附錄:圖表資料

第17章 附錄:企業·組織清單

目錄

Example Insights:

A number of companies have put in significant efforts to develop innovative cell isolation solutions and affiliated components based on novel approaches, for use across a variety of cell types and application areas.

Overview:

Advances in the fields of cell biology and regenerative medicine have led to the development of various cell-based therapies, which, developers claim, possess the potential to treat a variety of clinical conditions. In 2018, it was reported that there were more than 1,000 clinical trials of such therapies, being conducted across the globe by over 900 industry players. Moreover, the total investment in the aforementioned clinical research efforts was estimated to be around USD 13 billion. Given the recent breakthroughs in clinical testing and the discovery of a variety of diagnostic biomarkers, the isolation of one or multiple cell types from a heterogenous population has not only become simpler, but also an integral part of modern clinical R&D. The applications of cell separation technologies are vast, starting from basic research to biological therapy development and manufacturing. However, conventional cell sorting techniques, including adherence-based sorting, membrane filtration-based sorting, and fluorescence - and magnetic-based sorting, are limited by exorbitant operational costs, time-consuming procedures, and the need for complex biochemical labels. As a result, the use of such techniques has, so far, been restricted in the more niche and emerging application areas.

Over the years, extensive research in the field of flow cytometry has enabled the development of a variety of novel technologies that are capable of efficiently isolating cells from tissue samples and / or heterogenous cell populations. In fact, since 2014, over 3,000 patents were reported to have been filed / granted related to such advanced techniques, indicating the rapid pace of innovation in this domain. Developers of the aforementioned technologies claim that these new techniques offer numerous benefits, including fast and precise cell sorting, reduced sample requirement, improved portability, reduced risk to cell viability, and negligible need for expensive biochemical / magnetic labels. Moreover, they have been shown to be compatible for use across a myriad of applications, including research studies (bacteriology, immunology, stem cell research, and viral titering and infectivity), biomedical diagnostics (circulating tumor cell detection, in vitro fertilization, and non-invasive prenatal diagnosis), biological therapy-related process operations (bio-banking, drug discovery, sample preparation, single cell sequencing, and tumor cell characterization), and cell-based therapeutics (B- or T-cell immunotherapies). Consequently, these techniques have captured the interest of several stakeholders in the biopharmaceutical industry. It is also worth highlighting that stakeholders in this domain have received significant support from both private and public investors.

Scope of the Report:

The ‘Novel Cell Sorting and Separation Market: Focus on Acoustophoresis, Buoyancy, Dielectrophoresis, Magnetophoretics, Microfluidics, Optoelectronics, Traceless Affinity, and Other Technologies, 2019-2030’ report features an extensive study of the current landscape and future outlook of the growing market for novel cell sorting and separation technologies (beyond conventional methods). The study presents detailed analyses of cell sorters, cell isolation kits, and affiliated consumables and reagents, that are based on the aforementioned technologies. Amongst other elements, the report features:

  • A detailed assessment of the current market landscape, featuring a comprehensive list of over 220 innovative cell sorters, cell isolation kits, and affiliated consumables and reagents, along with information on their respective specifications (such as size, weight, cell flow rate, cell sort rate, cell analysis rate, cell purity and viability, process time, and operating temperature and pressure), cell sorting technology (acoustophoresis, buoyancy-activated, dielectrophoresis, magnetic levitation, microfluidics, optoelectronics, photoacoustics, traceless affinity, and others), type of cell (animal cells, cancer cells, immune cells, microbial cells, red blood cells / platelets, stem cells, and others), cell separation approach (positive selection, negative selection and depletion), basis for separation (cell morphology and physiology, cell size and density, surface biomarkers, surface charge and adhesion, and others), and end use / application (research studies, biomedical diagnostics, biological therapy-related process operations, and cell-based therapeutics).
  • An insightful company competitiveness analysis, taking into consideration the supplier power (based on size of employee base and experience in this segment of the industry) and portfolio-related parameters, such as number of products offered, number of target cells, end use(s) / application(s), and key product specification(s).
  • Comprehensive profiles of key industry players (shortlisted on the basis of company competitiveness analysis scores) that are currently offering novel cell sorters / consumables and cell isolation kits, featuring an overview of the company, its financial information (if available), and a detailed description of its proprietary product(s). Each profile also includes a list of recent developments, highlighting the key achievements, partnership activity, and the likely strategies that may be adopted by these players to fuel growth in the foreseen future.
  • An in-depth analysis of the patents that have been filed / granted related to novel cell sorting and separation technologies, since 2014. It highlights the key trends associated with these patents, across patent type, regional applicability, CPC classification, emerging focus areas, leading industry players (in terms of number of patents filed / granted), and current intellectual property-related benchmarks and valuation.
  • A detailed publication analysis of more than 200 peer-reviewed, scientific articles that have been published since 2014, highlighting the research focus within the industry. It also highlights the key trends observed across the publications, including information on innovative technologies, potential application areas, target disease indications, type of cell, and analysis based on various relevant parameters, such as year of publication, and most popular journals (in terms of number of articles published in the given time period) within this domain.
  • An analysis of the partnerships that have been established in the domain, in the period 2014-Q1 2019, covering R&D collaborations, licensing agreements, distribution agreements, mergers / acquisitions, asset purchase agreements, product development agreements, product utilization agreements, and other relevant deals.
  • An analysis of the investments made at various stages of development, such as seed financing, venture capital financing, debt financing, grants / awards, capital raised from IPOs and subsequent offerings, by companies that are engaged in this field.
  • An analysis to estimate the likely demand for novel cell sorting products and solutions across key application areas, including research studies, clinical diagnostics, cell-based therapeutics, and other applications, in different global regions for the period 2019-2030.

One of the key objectives of the report was to understand the primary growth drivers and estimate the future size of the novel cell sorting and separation market. Based on multiple parameters, such as potential application areas, likely adoption rate and expected pricing, we have provided an informed estimate on the likely evolution of the market, over the period 2019-2030. In addition, we have provided the likely distribution of the current and forecasted opportunity across [A] potential application areas (research studies, clinical diagnostics, cell-based therapeutics, and other applications), [B] end users (academic institutes, clinical testing labs, hospitals, and commercial organizations), [C] type of offering (cell sorters, and consumables and isolation kits), [D] cell sorting technology (buoyancy-activated, magnetophoretics, microfluidics, optoelectronics, and other advanced technologies), [E] type of cell (adult stem cells, CAR-T cells, circulating fetal cells, circulating tumor cells, dendritic cells, embryonic stem cells, insect cells, induced pluripotent stem cells, microbial cells, sperm cells, TCR cells, TILs, and tumor cells / cancer cells), [F] size of cell (< 5 μm, 5-10 μm, 10-15 μm, 15-25 μm, and > 25 μm), and [G] key geographical regions (North America, Europe and Asia-Pacific). In order to account for the uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios portraying the conservative, base and optimistic tracks of the industry's evolution.

The opinions and insights presented in this study were also influenced by discussions conducted with multiple stakeholders in this domain. The report features detailed transcripts of interviews held with the following individuals (in alphabetical order of organization names):

  • John Younger (Co-founder and Chief Technology Officer, Akadeum Life Sciences)
  • Sean Hart (Chief Executive Officer and Chief Scientific Officer, LumaCyte)
  • Soohee Cho (Product Manager, Namocell)

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

Chapter Outlines:

Chapter 2 is an executive summary of the insights captured in our research. It offers a high-level view on the likely evolution of novel cell sorting and separation market in the mid-long term.

Chapter 3 is an introductory chapter that presents a general overview of cell sorting and separation, including a brief history of development, and information on the basic components and principle of operation of a cell sorter. Further, it features a detailed discussion on conventional cell separation techniques and the various challenges associated with their use across different application areas. The chapter also includes detailed sections on the novel cell sorting and separation technologies (such as acoustophoresis, buoyancy-activated, dielectrophoresis, magnetic levitation, microfluidics, optoelectronics, photoacoustics, traceless affinity, and others), highlighting their advantages and challenges. Further, it features a discussion on the key growth drivers and roadblocks related to modern cell sorting technologies, as well as upcoming trends that the field is expected to witness in the coming years.

Chapter 4 includes information on more than 200 innovative cell sorters, cell isolation kits, and affiliated consumables and reagents, along with details on their respective specifications (such as size, weight, cell flow rate, cell sort rate, cell analysis rate, cell purity and viability, process time, and operating temperature and pressure), cell sorting technology (acoustophoresis, buoyancy-activated, dielectrophoresis, magnetic levitation, microfluidics, optoelectronics, photoacoustics, traceless affinity, and others), type of cell (animal cells, cancer cells, microbial cells, red blood cells / platelets, stem cells, and others), cell separation approach (positive selection, negative selection and depletion), basis for separation (cell morphology and physiology, cell size and density, surface biomarkers, surface charge and adhesion, and others), and end use / application (research studies, biomedical diagnostics, biological therapy-related process operations, and cell-based therapeutics). The chapter also highlights the contributions of various companies engaged in this domain, presenting detailed analyses, based on their year of establishment, size of employee base, geographical presence, and type of offering.

Chapter 5 features an insightful competitiveness analysis of the companies engaged in novel cell sorting and separation domain, based on various parameters, such as number of products offered, number of target cells, end use(s) / application(s), and key product specification(s). In the chapter, stakeholder entities have been plotted on a 2X2 matrix, featuring a company's Supplier Power (based on size of employee base and experience in this segment of the industry) and Company Competitiveness as the two axes.

Chapter 6 includes elaborate profiles of key industry players (shortlisted on the basis of company competitiveness analysis scores) that are offering novel cell sorters / sorting technologies; each profile features an overview of the company, its financial information (if available), and a detailed description of its proprietary product(s). Each profile also includes a list of recent developments, highlighting the key achievements, partnership activity, and the likely strategies that may be adopted by these players to fuel growth, in the foreseen future.

Chapter 7 includes detailed profiles of key industry players (shortlisted on the basis of company competitiveness analysis scores) that are offering novel consumables and cell isolation kits; each profile features an overview of the company, its financial information (if available), and a detailed description of its proprietary product(s). Each profile also includes a list of recent developments, highlighting the key achievements, partnership activity, and the likely strategies that may be adopted by these players to fuel growth, in the foreseen future.

Chapter 8 provides an in-depth patent analysis to provide an overview of how the industry is evolving from the R&D perspective. For this analysis, we considered those patents that have been filed / granted related to novel cell sorting and separation technologies, since 2014. The analysis also highlights the key trends associated with these patents, across patent type, regional applicability, CPC classification, emerging focus areas, leading industry players (in terms of number of patents filed / granted), and current intellectual property-related benchmarks and valuation.

Chapter 9 presents a detailed publication analysis of more than 200 peer-reviewed, scientific articles that have been published since 2014, highlighting the research focus within the industry. It also highlights the key trends observed across the publications, including information on innovative technologies, potential application areas, target disease indications, type of cell, and analyses based on various relevant parameters, such as year of publication, and most popular journals (in terms of number of articles published in the given time period) within this domain.

Chapter 10 features an elaborate analysis and discussion of partnerships / collaborations that have been established in this domain in the period 2014-Q1 2019. It includes a brief description of various types of partnership models (such as R&D collaborations, licensing agreements, distribution agreements, mergers / acquisitions, asset purchase agreements, product development agreements, product utilization agreements, and others) that have been employed by stakeholders within this domain. It also consists of a schematic representation showcasing the players that have established the maximum number of alliances related to novel cell sorting and separation technologies. Furthermore, we have provided a world map representation of all the deals inked in this field, highlighting those that have been established within and across different continents.

Chapter 11 provides information on funding instances and investments that have been made within the novel cell sorting and separation domain. The chapter includes details on various types of investments (such as seed financing, venture capital financing, debt financing, grants, capital raised from IPOs and subsequent offerings) received by companies in the period 2014-Q1 2019, highlighting the growing interest of the venture capital community and other strategic investors in this domain.

Chapter 12 provides an overview of the demand for novel cell sorting products and solutions across key application areas, including research studies, clinical diagnostics, cell-based therapeutics, and other applications, in the contemporary market. In order to estimate the aforementioned demand, we considered the number of ongoing / completed research studies, diagnostic tests and cell-based therapies under development across different geographies. We also estimated the likely adoption of such products and solutions across key application areas, over the period 2019-2030.

Chapter 13 features a comprehensive market forecast, highlighting the future potential of novel cell sorting and separation market till 2030, based on multiple parameters, such as potential application areas, likely adoption rate and expected pricing. In addition, we estimated the likely distribution of the current and forecasted opportunity across [A] potential application areas (research studies, clinical diagnostics, cell-based therapeutics, and other applications), [B] end users (academic institutes, clinical testing labs, hospitals, and commercial organizations), [C] type of offering (cell sorters, and consumables and isolation kits), [D] cell sorting technology (buoyancy-activated, magnetophoretics, microfluidics, optoelectronics, and other advanced technologies), [E] type of cell (adult stem cells, CAR-T cells, circulating fetal cells, circulating tumor cells, dendritic cells, embryonic stem cells, insect cells, induced pluripotent stem cells, microbial cells, sperm cells, TCR cells, TILs, and tumor cells / cancer cells), [F] size of cell (< 5 μm, 5-10 μm, 10-15 μm, 15-25 μm, and > 25 μm), and [G] key geographical regions (North America, Europe and Asia-Pacific). We adopted a bottom up approach, backed by robust data and credible inputs from primary research, to estimate the likely size of the market, both in terms of value (USD billion) and volume (number of products).

Chapter 14 is a collection of executive insights of the discussions that were held with various key stakeholders in this market. The chapter provides a brief overview of the companies and details of interviews held with John Younger (Co-founder and Chief Technology Officer, Akadeum Life Sciences), Sean Hart (Chief Executive Officer and Chief Scientific Officer, LumaCyte), and Soohee Cho (Product Manager, Namocell).

Chapter 15 is a summary of the overall report. In this chapter, we have provided a list of key takeaways from the report, and expressed our independent opinion related to the research and analysis described in the previous chapters.

Chapter 16 is an appendix, which provides tabulated data and numbers for all the figures provided in the report.

Chapter 17 is an appendix, which contains the list of companies and organizations mentioned in the report.

Table of Contents

1. PREFACE

  • 1.1. Scope of the Report
  • 1.2. Research Methodology
  • 1.3. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

  • 3.1. Context and Background
  • 3.2. Introduction to Cell Sorting and Separation
    • 3.2.1. Historical Overview
    • 3.2.2. Basic Components and Principle of Operation
    • 3.2.3. Cellular Characteristics Considered for Cell Sorting and Separation
      • 3.2.3.1. Cell Size and Density
      • 3.2.3.2. Hydrodynamic Properties
      • 3.2.3.3. Polarizability, Electrical Impedance and Magnetic Susceptibility
      • 3.2.3.4. Surface Charge and Adhesion
    • 3.2.4. Conventional Cell Sorting and Separation Methods
      • 3.2.4.1. Adhesion-based Sorting
      • 3.2.4.2. Density Gradient Centrifugation Sorting
      • 3.2.4.3. Fluorescence-activated Sorting
      • 3.2.4.4. Magnetic-activated Sorting
      • 3.2.4.5. Membrane Filtration Sorting
    • 3.2.5. Limitations of Conventional Cell Sorting and Separation Methods
  • 3.3. Novel Cell Sorting and Separation Technologies
    • 3.3.1. Buoyancy-activated Sorting
    • 3.3.2. Microfluidics-based Sorting
      • 3.3.2.1. Microfluidics-based Active Sorting Technologies
        • 3.3.2.1.1. Acoustic Sorting
        • 3.3.2.1.2. Aqueous Two-Phase Sorting
        • 3.3.2.1.3. Electrophoretic Sorting
        • 3.3.2.1.4. Magnetic Levitation-based Sorting
        • 3.3.2.1.5. Optoelectronics-based Sorting
      • 3.3.2.2. Microfluidics-based Passive Sorting Technologies
        • 3.3.2.2.1. Biomimetic Sorting
        • 3.3.2.2.2. Deterministic Lateral Displacement Sorting
        • 3.3.2.2.3. Field Flow Fractionation Sorting
        • 3.3.2.2.4. Gravity and Sedimentation Sorting
        • 3.3.2.2.5. Hydrodynamic Sorting
        • 3.3.2.2.6. Inertia-based Sorting
        • 3.3.2.2.7. Microfiltration Sorting
        • 3.3.2.2.8. Microstructures-based Sorting
    • 3.3.3. Other Types of Cell Sorting and Separation Technologies
      • 3.3.3.1. Density Difference Amplification-based Sorting
      • 3.3.3.2. SpheriTech Purification and Sorting
      • 3.3.3.3. Traceless Affinity-based Sorting
  • 3.4. Key Applications of Novel Cell Sorting and Separation Technologies
    • 3.4.1. Clinical Research
    • 3.4.2. Biomedical Diagnostics
    • 3.4.3. Cell-based Therapeutics
  • 3.5. Growth Drivers and Roadblocks
  • 3.6. Recent Developments and Upcoming Trends

4. CURRENT MARKET LANDSCAPE

  • 4.1. Chapter Overview
  • 4.2. Novel Cell Sorting Products and Solutions: Overall Market Landscape
    • 4.2.1. Analysis by Type of Product
    • 4.2.2. Analysis by Basis for Separation
    • 4.2.3. Analysis by Type of Technology
    • 4.2.4. Analysis by Cell Separation Approach
    • 4.2.5. Analysis by Type of Cell
  • 4.3. Novel Cell Sorting Products and Solutions: Developer Landscape
    • 4.3.1. Analysis by Year of Establishment
    • 4.3.2. Analysis by Location of Headquarters
    • 4.3.3. Analysis by Size of Company
    • 4.3.4. Analysis by Type of Offering
    • 4.3.5. Analysis by End Use / Application
    • 4.3.6. Leading Developers: Analysis by Number of Products
    • 4.3.7. Grid Analysis by Company Size, Type of Offering and End Use / Application

5. COMPANY COMPETITIVENESS ANALYSIS

  • 5.1. Chapter Overview
  • 5.2. Methodology
  • 5.3. Assumptions and Key Parameters
  • 5.4. Novel Cell Sorting Products and Solutions Providers: Company Competitiveness Analysis
    • 5.4.1. Small-sized Companies
    • 5.4.2. Mid-sized Companies
    • 5.4.3. Large Companies

6. PROFILES: COMPANIES OFFERING NOVEL CELL SORTERS / SORTING TECHNOLOGIES

  • 6.1. Chapter Overview
  • 6.2. NanoCellect Biomedical
    • 6.2.1. Company Overview
    • 6.2.2. Financial Information
    • 6.2.3. WOLF® Cell Sorter, N1® Single Cell Dispenser: Product Description
    • 6.2.4. Recent Developments and Future Outlook
  • 6.3. Innovative Biochips
    • 6.3.1. Company Overview
    • 6.3.2 Financial Information
    • 6.3.3. SMART ALIQUOTOR, SMART ALIQUOTOR COMPACT EDITION, SMART ALIQUOTOR EXTENDED EDITION: Product Description
    • 6.3.4. Recent Developments and Future Outlook
  • 6.4. Cesca Therapeutics
    • 6.4.1. Company Overview
    • 6.4.2. Financial Information
    • 6.4.3. AUTOXPRESS®, CAR-TXPRESS™, CELLXPRESS™: Product Description
    • 6.4.4. Recent Developments and Future Outlook
  • 6.5. Fluidigm
    • 6.5.1. Company Overview
    • 6.5.2. Financial Information
    • 6.5.3. C1™ System: Product Description
    • 6.5.4. Recent Developments and Future Outlook
  • 6.6. LumaCyte
    • 6.6.1. Company Overview
    • 6.6.2. Financial Information
    • 6.6.3. Radiance™: Product Description
    • 6.6.4. Recent Developments and Future Outlook
  • 6.7. Union Biometrica
    • 6.7.1. Company Overview
    • 6.7.2. Financial Information
    • 6.7.3. COPAS™ FP, BioSorter®: Product Description
    • 6.7.4. Recent Developments and Future Outlook
  • 6.8. LevitasBio
    • 6.8.1. Company Overview
    • 6.8.2. Financial Information
    • 6.8.3. LeviCell System: Product Description
    • 6.8.4. Recent Developments and Future Outlook
  • 6.9. RareCyte®
    • 6.9.1. Company Overview
    • 6.9.2. Financial Information
    • 6.9.3. AccuCyte® Sample Preparation System: Product Description
    • 6.9.4. Recent Developments and Future Outlook
  • 6.10. Cytonome
    • 6.10.1. Cytonome Viva™, Cytonome Hydris™, Cytonome GigaSort™: Product Description
    • 6.10.2. Recent Developments and Future Outlook
  • 6.11. Namocell
    • 6.11.1. Namo™ Single Cell Dispenser, Hana™ Single Cell Dispenser: Product Description
    • 6.11.2. Recent Developments and Future Outlook

7. PROFILES: COMPANIES OFFERING NOVEL CONSUMABLES AND ISOLATION KITS

  • 7.1. Chapter Overview
  • 7.2. STEMCELL Technologies
    • 7.2.1. Company Overview
    • 7.2.2. Financial Information
    • 7.2.3. Product Portfolio
    • 7.2.4. Recent Developments and Future Outlook
  • 7.3. Akadeum Life Sciences
    • 7.3.1. Company Overview
    • 7.3.2. Financial Information
    • 7.3.3. Product Portfolio
    • 7.3.4. Recent Developments and Future Outlook
  • 7.4. QIAGEN
    • 7.4.1. Company Overview
    • 7.4.2. Financial Information
    • 7.4.3. Product Portfolio
    • 7.4.4. Recent Developments and Future Outlook
  • 7.5. RareCyte®
    • 7.5.1. Company Overview
    • 7.5.2. Financial Information
    • 7.5.3. Product Portfolio
    • 7.5.4. Recent Developments and Future Outlook
  • 7.6. ScreenCell
    • 7.6.1. Company Overview
    • 7.6.2. Product Portfolio
    • 7.6.3. Recent Developments and Future Outlook

8. PATENT ANALYSIS

  • 8.1. Chapter Overview
  • 8.2. Scope and Methodology
  • 8.3. Novel Cell Sorting Products and Solutions: Patent Analysis
    • 8.3.1. Analysis by Publication Year
    • 8.3.2. Analysis by Geographical Location
    • 8.3.3 Analysis by CPC Symbols
    • 8.3.4. Emerging Focus Areas
    • 8.3.5. Leading Players: Analysis by Number of Patents
  • 8.4. Novel Cell Sorting Products and Solutions: Patent Benchmarking Analysis (Industry Players)
    • 8.4.1. Analysis by Patent Characteristics
    • 8.4.2. Analysis by Geographical Location
  • 8.5. Novel Cell Sorting Products and Solutions: Patent Valuation Analysis
  • 8.6. Leading Patents: Analysis by Number of Citations

9. PUBLICATION ANALYSIS

  • 9.1. Chapter Overview
  • 9.2. Scope and Methodology
  • 9.3. Novel Cell Sorting Products and Solutions: Publication Analysis
    • 9.3.1. Analysis by Year of Publication
    • 9.3.2. Emerging Focus Areas
    • 9.3.3. Analysis by Cell Sorting Technology
    • 9.3.4. Analysis by Application Area
    • 9.3.5. Analysis by Type of Cell
    • 9.3.6. Analysis by Target Disease Indication
    • 9.3.7. Analysis by Type of Organization Involved
    • 9.3.8. Leading Players: Analysis by Number of Publications
    • 9.3.9. Leading Players: Geographical Analysis by Number of Publications
    • 9.3.10. Key Journals: Analysis by Number of Publications

10. PARTNERSHIPS AND COLLABORATIONS

  • 10.1. Chapter Overview
  • 10.2. Partnership Models
  • 10.3. Novel Cell Sorting Products and Solutions: Recent Partnerships and Collaborations
    • 10.3.1. Analysis by Year of Partnership
    • 10.3.2. Analysis by Type of Partnership
    • 10.3.3. Analysis by Cell Sorting Technology
    • 10.3.4. Analysis by Type of Partner
    • 10.3.5. Most Active Players: Analysis by Number of Partnerships
    • 10.3.6. Geographical Analysis
      • 10.3.6.1. Most Active Players
      • 10.3.6.2. Intercontinental and Intracontinental Agreements

11. FUNDING AND INVESTMENT ANALYSIS

  • 11.1. Chapter Overview
  • 11.2. Types of Funding
  • 11.3. Novel Cell Sorting Products and Solutions: Recent Funding Instances
    • 11.3.1. Analysis by Number of Funding Instances
    • 11.3.2. Analysis by Amount Invested
    • 11.3.3. Analysis by Type of Funding
    • 11.3.4. Analysis by Number of Funding Instances and Amount Invested across Different Cell Sorting Technologies
    • 11.3.5. Most Active Players: Analysis by Number of Funding Instances
    • 11.3.6. Most Active Players: Analysis by Amount Invested
    • 11.3.7. Most Active Investors: Analysis by Number of Instances
    • 11.3.8. Geographical Analysis by Amount Invested
  • 11.4. Concluding Remarks

12. DEMAND ANALYSIS

  • 12.1. Chapter Overview
  • 12.2 Key Assumptions and Methodology
  • 12.3. Global Demand for Novel Cell Sorting Products and Solutions, 2019-2030
    • 12.3.1. Global Demand for Novel Cell Sorting Products and Solutions: Distribution by End Use / Application
      • 12.3.1.1. Global Demand for Novel Cell Sorting Products and Solutions for Research Studies, 2019-2030
      • 12.3.1.2. Global Demand for Novel Cell Sorting Products and Solutions for Circulating Tumor Cell Detection, 2019-2030
      • 12.3.1.3. Global Demand for Novel Cell Sorting Products and Solutions for In vitro Fertilization, 2019-2030
      • 12.3.1.4. Global Demand for Novel Cell Sorting Products and Solutions for Non-Invasive Prenatal Diagnostics, 2019-2030
      • 12.3.1.5. Global Demand for Novel Cell Sorting Products and Solutions for Cell-based Therapeutics, 2019-2030
    • 12.3.2. Global Demand for Novel Cell Sorting Products and Solutions: Distribution by Geography and End Use / Application
      • 12.3.2.1. Demand for Novel Cell Sorting Products and Solutions in North America, 2019-2030
        • 12.3.2.1.1. Demand for Novel Cell Sorting Products and Solutions in North America for Research Studies, 2019-2030
        • 12.3.2.1.2. Demand for Novel Cell Sorting Products and Solutions in North America for Circulating Tumor Cell Detection, 2019-2030
        • 12.3.2.1.3. Demand for Novel Cell Sorting Products and Solutions in North America for In vitro Fertilization, 2019-2030
        • 12.3.2.1.4. Demand for Novel Cell Sorting Products and Solutions in North America for Non-Invasive Prenatal Diagnosis, 2019-2030
        • 12.3.2.1.5. Demand for Novel Cell Sorting Products and Solutions in North America for Cell-based Therapeutics, 2019-2030
      • 12.3.2.2. Demand for Novel Cell Sorting Products and Solutions in Europe, 2019-2030
        • 12.3.2.2.1. Demand for Novel Cell Sorting Products and Solutions in Europe for Research Studies, 2019-2030
        • 12.3.2.2.2. Demand for Novel Cell Sorting Products and Solutions in Europe for Circulating Tumor Cell Detection, 2019-2030
        • 12.3.2.2.3. Demand for Novel Cell Sorting Products and Solutions in Europe for In vitro Fertilization, 2019-2030
        • 12.3.2.2.4. Demand for Novel Cell Sorting Products and Solutions in Europe for Non-Invasive Prenatal Diagnosis, 2019-2030
        • 12.3.2.2.5. Demand for Novel Cell Sorting Products and Solutions in Europe for Cell-based Therapeutics, 2019-2030
      • 12.3.2.3. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific, 2019-2030
        • 12.3.2.3.1. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Research Studies, 2019-2030
        • 12.3.2.3.2. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Circulating Tumor Cell Detection, 2019-2030
        • 12.3.2.3.3. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for In vitro Fertilization, 2019-2030
        • 12.3.2.3.4. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Non-Invasive Prenatal Diagnosis, 2019-2030
        • 12.3.2.3.5. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Cell-based Therapeutics, 2019-2030

13. MARKET FORECAST

  • 13.1. Chapter Overview
  • 13.2. Key Assumptions and Forecast Methodology
  • 13.3. Overall Novel Cell Sorting Products and Solutions Market
    • 13.3.1. Overall Novel Cell Sorting Products and Solutions Market, 2019-2030 (By Value)
    • 13.3.2 Overall Novel Cell Sorting Products and Solutions Market, 2019-2030 (By Volume)
  • 13.4. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Offering
    • 13.4.1. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Offering, 2019-2030 (By Value)
      • 13.4.1.1. Novel Cell Sorting Products and Solutions Market for Cell Sorters, 2019-2030 (By Value)
      • 13.4.1.2. Novel Cell Sorting Products and Solutions Market for Consumables and Isolation Kits, 2019-2030 (By Value)
    • 13.4.2. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Offering, 2019-2030 (By Volume)
      • 13.4.2.1. Novel Cell Sorting Products and Solutions Market for Cell Sorters, 2019-2030 (By Volume)
      • 13.4.2.2. Novel Cell Sorting Products and Solutions Market for Consumables and Isolation Kits, 2019-2030 (By Volume)
  • 13.5. Overall Novel Cell Sorting Products and Solutions Market: Distribution by End Use / Application
    • 13.5.1. Overall Novel Cell Sorting Products and Solutions Market: Distribution by End Use / Application, 2019-2030 (By Value)
      • 13.5.1.1. Novel Cell Sorting Products and Solutions Market for Research Studies, 2019-2030 (By Value)
      • 13.5.1.2. Novel Cell Sorting Products and Solutions Market for Circulating Tumor Cell Detection, 2019-2030 (By Value)
      • 13.5.1.3. Novel Cell Sorting Products and Solutions Market for In vitro Fertilization, 2019-2030 (By Value)
      • 13.5.1.4. Novel Cell Sorting Products and Solutions Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
      • 13.5.1.5. Novel Cell Sorting Products and Solutions Market for Cell-based Therapeutics, 2019-2030 (By Value)
    • 13.5.2. Overall Novel Cell Products and Solutions Market: Distribution by End Use / Application, 2019-2030 (By Volume)
      • 13.5.2.1. Novel Cell Sorting Products and Solutions Market for Research Studies, 2019-2030 (By Volume)
      • 13.5.2.2. Novel Cell Sorting Products and Solutions Market for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
      • 13.5.2.3. Novel Cell Sorting Products and Solutions Market for In vitro Fertilization, 2019-2030 (By Volume)
      • 13.5.2.4. Novel Cell Sorting Products and Solutions Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
      • 13.5.2.5. Novel Cell Sorting Products and Solutions Market for Cell-based Therapeutics, 2019-2030 (By Volume)
  • 13.6. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Cell Sorting Technology
    • 13.6.1. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Cell Sorting Technology, 2019-2030 (By Value)
      • 13.6.1.1. Novel Cell Sorting Products and Solutions Market for Buoyancy-activated, 2019-2030 (By Value)
      • 13.6.1.2. Novel Cell Sorting Products and Solutions Market for Magnetic Levitation, 2019-2030 (By Value)
      • 13.6.1.3. Novel Cell Sorting Products and Solutions Market for Microfluidics, 2019-2030 (By Value)
      • 13.6.1.4. Novel Cell Sorting Products and Solutions Market for Optoelectronics, 2019-2030 (By Value)
      • 13.6.1.5. Novel Cell Sorting Products and Solutions Market for Other Advanced Technologies, 2019-2030 (By Value)
    • 13.6.2. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Cell Sorting Technology, 2019-2030 (By Volume)
      • 13.6.2.1. Novel Cell Sorting Products and Solutions Market for Buoyancy-activated, 2019-2030 (By Volume)
      • 13.6.2.2. Novel Cell Sorting Products and Solutions Market for Magnetic Levitation, 2019-2030 (By Volume)
      • 13.6.2.3. Novel Cell Sorting Products and Solutions Market for Microfluidics, 2019-2030 (By Volume)
      • 13.6.2.4. Novel Cell Sorting Products and Solutions Market for Optoelectronics, 2019-2030 (By Volume)
      • 13.6.2.5. Novel Cell Sorting Products and Solutions Market for Other Advanced Technologies, 2019-2030 (By Volume)
  • 13.7. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Cell
    • 13.7.1. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Cell, 2019-2030 (By Value)
      • 13.7.1.1. Novel Cell Sorting Products and Solutions Market for Animal Cells, 2019-2030 (By Value)
      • 13.7.1.2. Novel Cell Sorting Products and Solutions Market for Cancer Cells, 2019-2030 (By Value)
      • 13.7.1.3. Novel Cell Sorting Products and Solutions Market for Immune Cells, 2019-2030 (By Value)
      • 13.7.1.4. Novel Cell Sorting Products and Solutions Market for Microbial Cells, 2019-2030 (By Value)
      • 13.7.1.5. Novel Cell Sorting Products and Solutions Market for Red Blood Cells / Platelets, 2019-2030 (By Value)
      • 13.7.1.6. Novel Cell Sorting Products and Solutions Market for Stem Cells, 2019-2030 (By Value)
    • 13.7.2. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Cell, 2019-2030 (By Volume)
      • 13.7.2.1. Novel Cell Sorting Products and Solutions Market for Animal Cells, 2019-2030 (By Volume)
      • 13.7.2.2. Novel Cell Sorting Products and Solutions Market for Cancer Cells, 2019-2030 (By Volume)
      • 13.7.2.3. Novel Cell Sorting Products and Solutions Market for Immune Cells, 2019-2030 (By Volume)
      • 13.7.2.4. Novel Cell Sorting Products and Solutions Market for Microbial Cells, 2019-2030 (By Volume)
      • 13.7.2.5. Novel Cell Sorting Products and Solutions Market for Red Blood Cells / Platelets, 2019-2030 (By Volume)
      • 13.7.2.6. Novel Cell Sorting Products and Solutions Market for Stem Cells, 2019-2030 (By Volume)
  • 13.8. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Geography
    • 13.8.1. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Geography, 2019-2030 (By Value)
      • 13.8.1.1. Novel Cell Sorting Products and Solutions Market in North America, 2019-2030 (By Value)
      • 13.8.1.2. Novel Cell Sorting Products and Solutions Market in Europe, 2019-2030 (By Value)
      • 13.8.1.3 Novel Cell Sorting Products and Solutions Market in Asia-Pacific, 2019-2030 (By Value)
    • 13.8.2. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Geography, 2019-2030 (By Volume)
      • 13.8.2.1. Novel Cell Sorting Products and Solutions Market in North America, 2019-2030 (By Volume)
      • 13.8.2.2. Novel Cell Sorting Products and Solutions Market in Europe, 2019-2030 (By Volume)
      • 13.8.2.3. Novel Cell Sorting Products and Solutions Market in Asia-Pacific, 2019-2030 (By Volume)
  • 13.9. Overall Novel Cell Sorting Products and Solutions Market: Distribution by End Use / Application Cell Sorting Technology and Type of Offering
    • 13.9.1. Overall Novel Cell Sorting Products and Solutions Market for Research Studies: Distribution by Cell Sorting Technology and Type of Offering (By Value)
      • 13.9.1.1. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Research Studies, 2019-2030 (By Value)
        • 13.9.1.1.1. Buoyancy-activated Cell Sorters Market for Research Studies, 2019-2030 (By Value)
        • 13.9.1.1.2. Buoyancy-activated Consumables and Isolation Kits Market for Research Studies, 2019-2030 (By Value)
      • 13.9.1.2. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Research Studies, 2019-2030 (By Value)
        • 13.9.1.2.1. Magnetic Levitation-based Cell Sorters Market for Research Studies, 2019-2030 (By Value)
        • 13.9.1.2.2. Magnetic Levitation-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (By Value)
      • 13.9.1.3. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Research Studies, 2019-2030 (By Value)
        • 13.9.1.3.1. Microfluidics-based Cell Sorters Market for Research Studies, 2019-2030 (By Value)
        • 13.9.1.3.2. Microfluidics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (By Value)
      • 13.9.1.4. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Research Studies, 2019-2030 (By Value)
        • 13.9.1.4.1. Optoelectronics-based Cell Sorters Market for Research Studies, 2019-2030 (By Value)
        • 13.9.1.4.2. Optoelectronics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (By Value)
      • 13.9.1.5. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Research Studies, 2019-2030 (By Value)
        • 13.9.1.5.1. Other Advanced Technologies-based Cell Sorters Market for Research Studies, 2019-2030 (By Value)
        • 13.9.1.5.2. Other Advanced Technologies-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (By Value)
    • 13.9.2. Overall Novel Cell Sorting Products and Solutions Market for Research Studies: Distribution by Cell Sorting Technology and Type of Offering (By Volume)
      • 13.9.2.1. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Research Studies, 2019-2030 (By Volume)
        • 13.9.2.1.1. Buoyancy-activated Cell Sorters Market for Research Studies, 2019-2030 (By Volume)
        • 13.9.2.1.2. Buoyancy-activated Consumables and Isolation Kits Market for Research Studies, 2019-2030 (By Volume)
      • 13.9.2.2. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Research Studies, 2019-2030 (By Volume)
        • 13.9.2.2.1. Magnetic Levitation-based Cell Sorters Market for Research Studies, 2019-2030 (By Volume)
        • 13.9.2.2.2. Magnetic Levitation-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (By Volume)
      • 13.9.2.3. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Research Studies, 2019-2030 (By Volume)
        • 13.9.2.3.1. Microfluidics-based Cell Sorters Market for Research Studies, 2019-2030 (By Volume)
        • 13.9.2.3.2. Microfluidics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (By Volume)
      • 13.9.2.4. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Research Studies, 2019-2030 (By Volume)
        • 13.9.2.4.1. Optoelectronics-based Cell Sorters Market for Research Studies, 2019-2030 (By Volume)
        • 13.9.2.4.2. Optoelectronics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (By Volume)
      • 13.9.2.5. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Research Studies, 2019-2030 (By Volume)
        • 13.9.2.5.1. Other Advanced Technologies-based Cell Sorters Market for Research Studies, 2019-2030 (By Volume)
        • 13.9.2.5.2. Other Advanced Technologies-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (By Volume)
    • 13.9.3. Overall Novel Cell Sorting Products and Solutions Market for Circulating Tumor Cell Detection: Distribution by Cell Sorting Technology and Type of Offering (By Value)
      • 13.9.3.1. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (By Value)
        • 13.9.3.1.1. Buoyancy-activated Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (By Value)
        • 13.9.3.1.2. Buoyancy-activated Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (By Value)
      • 13.9.3.2. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (By Value)
        • 13.9.3.2.1. Magnetic Levitation-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (By Value)
        • 13.9.3.2.2. Magnetic Levitation-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (By Value)
      • 13.9.3.3. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (By Value)
        • 13.9.3.3.1. Microfluidics-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (By Value)
        • 13.9.3.3.2. Microfluidics-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (By Value)
      • 13.9.3.4. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (By Value)
        • 13.9.3.4.1. Optoelectronics-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (By Value)
        • 13.9.3.4.2. Optoelectronics-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (By Value)
      • 13.9.3.5. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (By Value)
        • 13.9.3.5.1. Other Advanced Technologies-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (By Value)
        • 13.9.3.5.2. Other Advanced Technologies-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (By Value)
    • 13.9.4. Overall Novel Cell Sorting Products and Solutions Market for Circulating Tumor Cell Detection: Distribution by Cell Sorting Technology and Type of Offering (By Volume)
      • 13.9.4.1. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
        • 13.9.4.1.1. Buoyancy-activated Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
        • 13.9.4.1.2. Buoyancy-activated Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
      • 13.9.4.2. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
        • 13.9.4.2.1. Magnetic Levitation-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
        • 13.9.4.2.2. Magnetic Levitation-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
      • 13.9.4.3. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
        • 13.9.4.3.1. Microfluidics-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
        • 13.9.4.3.2. Microfluidics-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
      • 13.9.4.4. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
        • 13.9.4.4.1. Optoelectronics-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
        • 13.9.4.4.2. Optoelectronics-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
      • 13.9.4.5. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
        • 13.9.4.5.1. Other Advanced Technologies-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
        • 13.9.4.5.2. Other Advanced Technologies-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (By Volume)
    • 13.9.5. Overall Novel Cell Sorting Products and Solutions Market for In vitro Fertilization: Distribution by Cell Sorting Technology and Type of Offering (By Value)
      • 13.9.5.1. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for In vitro Fertilization, 2019-2030 (By Value)
        • 13.9.5.1.1. Buoyancy-activated Cell Sorters Market for In vitro Fertilization, 2019-2030 (By Value)
        • 13.9.5.1.2. Buoyancy-activated Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (By Value)
      • 13.9.5.2. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for In vitro Fertilization, 2019-2030 (By Value)
        • 13.9.5.2.1. Magnetic Levitation-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (By Value)
        • 13.9.5.2.2. Magnetic Levitation-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (By Value)
      • 13.9.5.3. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for In vitro Fertilization, 2019-2030 (By Value)
        • 13.9.5.3.1. Microfluidics-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (By Value)
        • 13.9.5.3.2. Microfluidics-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (By Value)
      • 13.9.5.4. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for In vitro Fertilization, 2019-2030 (By Value)
        • 13.9.5.4.1. Optoelectronics-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (By Value)
        • 13.9.5.4.2. Optoelectronics-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (By Value)
      • 13.9.5.5. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for In vitro Fertilization, 2019-2030 (By Value)
        • 13.9.5.5.1. Other Advanced Technologies-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (By Value)
        • 13.9.5.5.2. Other Advanced Technologies-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (By Value)
    • 13.9.6. Overall Novel Cell Sorting Products and Solutions Market for In vitro Fertilization: Distribution by Cell Sorting Technology and Type of Offering (By Volume)
      • 13.9.6.1. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for In vitro Fertilization, 2019-2030 (By Volume)
        • 13.9.6.1.1. Buoyancy-activated Cell Sorters Market for In vitro Fertilization, 2019-2030 (By Volume)
        • 13.9.6.1.2. Buoyancy-activated Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (By Volume)
      • 13.9.6.2. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for In vitro Fertilization, 2019-2030 (By Volume)
        • 13.9.6.2.1. Magnetic Levitation-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (By Volume)
        • 13.9.6.2.2. Magnetic Levitation-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (By Volume)
      • 13.9.6.3. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for In vitro Fertilization, 2019-2030 (By Volume)
        • 13.9.6.3.1. Microfluidics-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (By Volume)
        • 13.9.6.3.2. Microfluidics-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (By Volume)
      • 13.9.6.4. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for In vitro Fertilization, 2019-2030 (By Volume)
        • 13.9.6.4.1. Optoelectronics-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (By Volume)
        • 13.9.6.4.2. Optoelectronics-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (By Volume)
      • 13.9.6.5. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for In vitro Fertilization, 2019-2030 (By Volume)
        • 13.9.6.5.1. Other Advanced Technologies-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (By Volume)
        • 13.9.6.5.2. Other Advanced Technologies-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (By Volume)
    • 13.9.7. Overall Novel Cell Sorting Products and Solutions Market for Non-Invasive Prenatal Diagnosis: Distribution by Cell Sorting Technology and Type of Offering (By Value)
      • 13.9.7.1. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
        • 13.9.7.1.1. Buoyancy-activated Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
        • 13.9.7.1.2. Buoyancy-activated Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
      • 13.9.7.2. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
        • 13.9.7.2.1. Magnetic Levitation-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
        • 13.9.7.2.2. Magnetic Levitation-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
      • 13.9.7.3. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
        • 13.9.7.3.1. Microfluidics-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
        • 13.9.7.3.2. Microfluidics-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
      • 13.9.7.4. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
        • 13.9.7.4.1. Optoelectronics-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
        • 13.9.7.4.2. Optoelectronics-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
      • 13.9.7.5. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
        • 13.9.7.5.1. Other Advanced Technologies-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
        • 13.9.7.5.2. Other Advanced Technologies-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Value)
    • 13.9.8. Overall Novel Cell Sorting Products and Solutions Market for Non-Invasive Prenatal Diagnosis: Distribution by Cell Sorting Technology and Type of Offering (By Volume)
      • 13.9.8.1. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
        • 13.9.8.1.1. Buoyancy-activated Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
        • 13.9.8.1.2. Buoyancy-activated Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
      • 13.9.8.2. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
        • 13.9.8.2.1. Magnetic Levitation-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
        • 13.9.8.2.2. Magnetic Levitation-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
      • 13.9.8.3. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
        • 13.9.8.3.1. Microfluidics-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
        • 13.9.8.3.2. Microfluidics-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
      • 13.9.8.4. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
        • 13.9.8.4.1. Optoelectronics-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
        • 13.9.8.4.2. Optoelectronics-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
      • 13.9.8.5. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
        • 13.9.8.5.1. Other Advanced Technologies-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
        • 13.9.8.5.2. Other Advanced Technologies-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (By Volume)
    • 13.9.9. Overall Novel Cell Sorting Products and Solutions Market for Cell-based Therapeutics: Distribution by Cell Sorting Technology and Type of Offering (By Value)
      • 13.9.9.1. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Cell-based Therapeutics, 2019-2030 (By Value)
        • 13.9.9.1.1. Buoyancy-activated Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (By Value)
        • 13.9.9.1.2. Buoyancy-activated Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (By Value)
      • 13.9.9.2. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (By Value)
        • 13.9.9.2.1. Magnetic Levitation-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (By Value)
        • 13.9.9.2.2. Magnetic Levitation-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (By Value)
      • 13.9.9.3. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (By Value)
        • 13.9.9.3.1. Microfluidics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (By Value)
        • 13.9.9.3.2. Microfluidics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (By Value)
      • 13.9.9.4. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (By Value)
        • 13.9.9.4.1. Optoelectronics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (By Value)
        • 13.9.9.4.2. Optoelectronics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (By Value)
      • 13.9.9.5. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (By Value)
        • 13.9.9.5.1. Other Advanced Technologies-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (By Value)
        • 13.9.9.5.2. Other Advanced Technologies-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (By Value)
    • 13.9.10. Overall Novel Cell Sorting Products and Solutions Market for Cell-based Therapeutics: Distribution by Cell Sorting Technology and Type of Offering (By Volume)
      • 13.9.10.1. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Cell-based Therapeutics, 2019-2030 (By Volume)
        • 13.9.10.1.1. Buoyancy-activated Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (By Volume)
        • 13.9.10.1.2. Buoyancy-activated Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (By Volume)
      • 13.9.10.2. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (By Volume)
        • 13.9.10.2.1. Magnetic Levitation-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (By Volume)
        • 13.9.10.2.2. Magnetic Levitation-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (By Volume)
      • 13.9.10.3. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (By Volume)
        • 13.9.10.3.1. Microfluidics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (By Volume)
        • 13.9.10.3.2. Microfluidics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (By Volume)
      • 13.9.10.4. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (By Volume)
        • 13.9.10.4.1. Optoelectronics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (By Volume)
        • 13.9.10.4.2. Optoelectronics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (By Volume)
      • 13.9.10.5. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (By Volume)
        • 13.9.10.5.1. Other Advanced Technologies-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (By Volume)
        • 13.9.10.5.2. Other Advanced Technologies-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (By Volume)

14. EXECUTIVE INSIGHTS

  • 14.1. Chapter Overview
  • 14.2. Akadeum Life Sciences
    • 14.2.1. Company Snapshot
    • 14.2.2. Interview Transcript: John Younger, Co-founder and Chief Technology Officer
  • 14.3. LumaCyte
    • 14.3.1. Company Snapshot
    • 14.3.2. Interview Transcript: Sean Hart, Chief Executive Officer and Chief Scientific Officer
  • 14.4. Namocell
    • 14.4.1. Company Snapshot
    • 14.4.2. Interview Transcript: Soohee Cho, Product Manager

15. CONCLUDING REMARKS

  • 15.1. Chapter Overview
  • 15.2. Key Takeaways

16. APPENDIX 1: TABULATED DATA

17. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List of Figures

  • Figure 3.1. Basic Components of a Cell Sorter
  • Figure 3.2. Limitations of Conventional Cell Sorting and Separation Methods
  • Figure 3.3. Classification of Novel Cell Sorting and Separation Technologies
  • Figure 3.4. Advantages and Challenges of Buoyancy-activated Cell Sorting
  • Figure 3.5. Advantages and Challenges of Microfluidics-based Cell Sorting
  • Figure 3.6. Key Applications of Novel Cell Sorting and Separation Technologies
  • Figure 3.7. Growth Drivers and Roadblocks to Novel Cell Sorting and Separation Technologies
  • Figure 3.8. Recent Developments and Upcoming Trends Related to Novel Cell Sorting and Separation Technologies
  • Figure 4.1. Novel Cell Sorting Products and Solutions: Distribution by Type of Product
  • Figure 4.2. Novel Cell Sorting Products and Solutions: Distribution by Basis for Separation
  • Figure 4.3. Novel Cell Sorting Products and Solutions: Distribution by Type of Cell Sorting Technology
  • Figure 4.4. Novel Cell Sorting Products and Solutions: Logo Landscape of Developers by Type of Cell Sorting Technology
  • Figure 4.5. Novel Cell Sorting Products and Solutions: Distribution by Cell Separation Approach
  • Figure 4.6. Novel Cell Sorting Products and Solutions: Distribution by Type of Cell
  • Figure 4.7. Popular Cell Types: Distribution by Number of Products
  • Figure 4.8. Novel Cell Sorting Products and Solutions: Distribution of Industry Players by Year of Establishment
  • Figure 4.9. Novel Cell Sorting Products and Solutions: Distribution of Industry Players by Geographical Location
  • Figure 4.10. Novel Cell Sorting Products and Solutions: Distribution of Industry Players by Company Size
  • Figure 4.11. Novel Cell Sorting Products and Solutions: Distribution of Industry Players by Type of Offering
  • Figure 4.12. Novel Cell Sorting Products and Solutions: Distribution by End Use / Application
  • Figure 4.13. Leading Developers: Distribution by Number of Products
  • Figure 4.14. Novel Cell Sorting Products and Solutions: Distribution of Industry Players by Company Size, Type of Offering and End Use / Application
  • Figure 5.1. Competitiveness Analysis of Small-sized Novel Cell Sorting Products and Solutions Providers
  • Figure 5.2. Competitiveness Analysis of Mid-sized Novel Cell Sorting Products and Solutions Providers
  • Figure 5.3. Competitiveness Analysis of Large Novel Cell Sorting Products and Solutions Providers
  • Figure 8.1. Patent Analysis: Distribution by Type
  • Figure 8.2. Patent Analysis: Cumulative Year-wise Trend, 2014-2018
  • Figure 8.3. Patent Analysis: Distribution by Geographical Location
  • Figure 8.4. Patent Analysis: Distribution by CPC Symbols (Top 20)
  • Figure 8.5. Patent Analysis: Emerging Focus Areas
  • Figure 8.6. Most Active Industry Players: Distribution by Number of Patents
  • Figure 8.7. Most Active Non-Industry Players: Distribution by Number of Patents
  • Figure 8.8. Patent Analysis: Benchmarking by Patent Characteristics
  • Figure 8.9. Patent Analysis: Benchmarking by Number of Patents Published across Different Geographies
  • Figure 8.10. Patent Analysis: Benchmarking by Number of International Patents
  • Figure 8.11. Patent Analysis: Distribution by Patent Age, 2014-2018
  • Figure 8.12. Patent Analysis: Distribution by Geography and Year of Publication, 2014-2018
  • Figure 8.13. Patent Analysis: Distribution by Relative Valuation
  • Figure 9.1. Publication Analysis: Cumulative Year-wise Trend, 2014-2018
  • Figure 9.2. Publication Analysis: Emerging Focus Areas
  • Figure 9.3. Publication Analysis: Distribution by Cell Sorting Technology
  • Figure 9.4. Publication Analysis: Distribution by End Use / Application Area
  • Figure 9.5. Publication Analysis: Distribution by Type of Cell
  • Figure 9.6. Publication Analysis: Distribution by Target Disease Indication
  • Figure 9.7. Publication Analysis: Distribution by Type of Organization Involved
  • Figure 9.8. Most Active Players: Distribution by Number of Publications
  • Figure 9.9. Most Active Players: Geographical Distribution by Number of Publications
  • Figure 9.10. Key Journals: Distribution by Number of Publications
  • Figure 10.1. Partnerships and Collaborations: Cumulative Year-wise Trend, 2014-Q1 2019
  • Figure 10.2. Partnerships and Collaborations: Distribution by Type of Partnership
  • Figure 10.3. Partnerships and Collaborations: Year-wise Trend by Type of Partnership
  • Figure 10.4. Partnerships and Collaborations: Distribution by Cell Sorting Technology
  • Figure 10.5. Partnerships and Collaborations: Year-wise Trend by Cell Sorting Technology
  • Figure 10.6. Partnerships and Collaborations: Distribution by Type of Partner
  • Figure 10.7. Most Active Players: Distribution by Number of Partnerships
  • Figure 10.8. Most Active Players: Geographical Distribution by Number of Partnerships
  • Figure 10.9. Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
  • Figure 11.1. Funding and Investments: Distribution of Industry Players by Year of Establishment and Type of Funding, 2014-Q1 2019
  • Figure 11.2. Funding and Investments: Distribution of Amount Invested by Focus Area and Type of Funding, 2014-Q1 2019
  • Figure 11.3. Funding and Investments: Cumulative Year-wise Trend, 2014-Q1 2019
  • Figure 11.4. Funding and Investments: Cumulative Amount Invested by Year, 2014-Q1 2019 (USD Million)
  • Figure 11.5. Funding and Investments: Distribution by Type of Funding
  • Figure 11.6. Funding and Investments: Distribution by Amount Invested and Type of Funding (USD Million)
  • Figure 11.7. Funding and Investments: Summary of Investments, 2014-Q1 2019 (USD Million)
  • Figure 11.8. Popular Cell Sorting Technologies: Distribution by Number of Funding Instances
  • Figure 11.9. Popular Cell Sorting Technologies: Distribution by Amount Invested (USD Million)
  • Figure 11.10. Funding and Investments: Year-wise Trend of Amount Invested across Different Cell Sorting Technologies, 2014-Q1 2019 (USD Million)
  • Figure 11.11. Most Active Players: Distribution by Number of Instances
  • Figure 11.12. Most Active Players: Distribution by Capital Amount Raised (USD Million)
  • Figure 11.13. Most Active Investors: Distribution by Number of Instances
  • Figure 11.14. Funding and Investments: Geographical Distribution by Amount Invested (USD Million)
  • Figure 11.15. Funding and Investment Summary
  • Figure 12.1. Global Demand for Novel Cell Sorting Products and Solutions, 2019-2030 (Million Units)
  • Figure 12.2. Global Demand for Novel Cell Sorting Products and Solutions for Research Studies, 2019-2030 (Million Units)
  • Figure 12.3. Global Demand for Novel Cell Sorting Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
  • Figure 12.4. Global Demand for Novel Cell Sorting Products and Solutions for In vitro Fertilization, 2019-2030 (Million Units)
  • Figure 12.5. Global Demand for Novel Cell Sorting Products and Solutions for Non-Invasive Prenatal Diagnostics, 2019-2030 (Million Units)
  • Figure 12.6. Global Demand for Novel Cell Sorting Products and Solutions for Cell-based Therapeutics, 2019-2030 (Million Units)
  • Figure 12.7. Demand for Novel Cell Sorting Products and Solutions in North America, 2019-2030 (Million Units)
  • Figure 12.8. Demand for Novel Cell Sorting Products and Solutions in North America for Research Studies, 2019-2030 (Million Units)
  • Figure 12.9. Demand for Novel Cell Sorting Products and Solutions in North America for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
  • Figure 12.10. Demand for Novel Cell Sorting Products and Solutions in North America for In vitro Fertilization, 2019-2030 (Million Units)
  • Figure 12.11. Demand for Novel Cell Sorting Products and Solutions in North America for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
  • Figure 12.12. Demand for Novel Cell Sorting Products and Solutions in North America for Cell-based Therapeutics, 2019-2030 (Million Units)
  • Figure 12.13. Demand for Novel Cell Sorting Products and Solutions in Europe, 2019-2030 (Million Units)
  • Figure 12.14. Demand for Novel Cell Sorting Products and Solutions in Europe for Research Studies, 2019-2030 (Million Units)
  • Figure 12.15. Demand for Novel Cell Sorting Products and Solutions in Europe for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
  • Figure 12.16. Demand for Novel Cell Sorting Products and Solutions in Europe for In vitro Fertilization, 2019-2030 (Million Units)
  • Figure 12.17. Demand for Novel Cell Sorting Products and Solutions in Europe for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
  • Figure 12.18. Demand for Novel Cell Sorting Products and Solutions in Europe for Cell-based Therapeutics, 2019-2030 (Million Units)
  • Figure 12.19. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific, 2019-2030 (Million Units)
  • Figure 12.20. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Research Studies, 2019-2030 (Million Units)
  • Figure 12.21. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
  • Figure 12.22. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for In vitro Fertilization, 2019-2030 (Million Units)
  • Figure 12.23. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
  • Figure 12.24. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Cell-based Therapeutics, 2019-2030 (Million Units)
  • Figure 13.1. Overall Novel Cell Sorting Products and Solutions Market, 2019-2030 (USD Million)
  • Figure 13.2. Overall Novel Cell Sorting Products and Solutions Market, 2019-2030 (Million Units)
  • Figure 13.3. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Offering, 2019-2030 (USD Million)
  • Figure 13.4. Novel Cell Sorting Products and Solutions Market for Cell Sorters, 2019-2030 (USD Million)
  • Figure 13.5. Novel Cell Sorting Products and Solutions Market for Consumables and Isolation Kits, 2019-2030 (USD Million)
  • Figure 13.6. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Offering, 2019-2030 (Million Units)
  • Figure 13.7. Novel Cell Sorting Products and Solutions Market for Cell Sorters, 2019-2030 (Million Units)
  • Figure 13.8. Novel Cell Sorting Products and Solutions Market for Consumables and Isolation Kits, 2019-2030 (Million Units)
  • Figure 13.9. Overall Novel Cell Sorting Products and Solutions Market: Distribution by End Use / Application, 2019-2030 (USD Million)
  • Figure 13.10. Novel Cell Sorting Products and Solutions Market for Research Studies, 2019-2030 (USD Million)
  • Figure 13.11. Novel Cell Sorting Products and Solutions Market for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
  • Figure 13.12. Novel Cell Sorting Products and Solutions Market for In vitro Fertilization, 2019-2030 (USD Million)
  • Figure 13.13. Novel Cell Sorting Products and Solutions Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
  • Figure 13.14. Novel Cell Sorting Products and Solutions Market for Cell-based Therapeutics, 2019-2030 (USD Million)
  • Figure 13.15. Overall Novel Cell Products and Solutions Market: Distribution by End Use / Application, 2019-2030 (Million Units)
  • Figure 13.16. Novel Cell Sorting Products and Solutions Market for Research Studies, 2019-2030 (Million Units)
  • Figure 13.17. Novel Cell Sorting Products and Solutions Market for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
  • Figure 13.18. Novel Cell Sorting Products and Solutions Market for In vitro Fertilization, 2019-2030 (Million Units)
  • Figure 13.19. Novel Cell Sorting Products and Solutions Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
  • Figure 13.20. Novel Cell Sorting Products and Solutions Market for Cell-based Therapeutics, 2019-2030 (Million Units)
  • Figure 13.21. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Cell Sorting Technology, 2019-2030 (USD Million)
  • Figure 13.22. Novel Cell Sorting Products and Solutions Market for Buoyancy-activated, 2019-2030 (USD Million)
  • Figure 13.23. Novel Cell Sorting Products and Solutions Market for Magnetic Levitation, 2019-2030 (USD Million)
  • Figure 13.24. Novel Cell Sorting Products and Solutions Market for Microfluidics, 2019-2030 (USD Million)
  • Figure 13.25. Novel Cell Sorting Products and Solutions Market for Optoelectronics, 2019-2030 (USD Million)
  • Figure 13.26. Novel Cell Sorting Products and Solutions Market for Other Advanced Technologies, 2019-2030 (USD Million)
  • Figure 13.27. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Cell Sorting Technology, 2019-2030 (Million Units)
  • Figure 13.28. Novel Cell Sorting Products and Solutions Market for Buoyancy-activated, 2019-2030 (Million Units)
  • Figure 13.29. Novel Cell Sorting Products and Solutions Market for Magnetic Levitation, 2019-2030 (Million Units)
  • Figure 13.30. Novel Cell Sorting Products and Solutions Market for Microfluidics, 2019-2030 (Million Units)
  • Figure 13.31. Novel Cell Sorting Products and Solutions Market for Optoelectronics, 2019-2030 (Million Units)
  • Figure 13.32. Novel Cell Sorting Products and Solutions Market for Other Advanced Technologies, 2019-2030 (Million Units)
  • Figure 13.33. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Cell, 2019-2030 (USD Million)
  • Figure 13.34. Novel Cell Sorting Products and Solutions Market for Animal Cells, 2019-2030 (USD Million)
  • Figure 13.35. Novel Cell Sorting Products and Solutions Market for Cancer Cells, 2019-2030 (USD Million)
  • Figure 13.36. Novel Cell Sorting Products and Solutions Market for Immune Cells, 2019-2030 (USD Million)
  • Figure 13.37. Novel Cell Sorting Products and Solutions Market for Microbial Cells, 2019-2030 (USD Million)
  • Figure 13.38. Novel Cell Sorting Products and Solutions Market for Red Blood Cells / Platelets, 2019-2030 (USD Million)
  • Figure 13.39. Novel Cell Sorting Products and Solutions Market for Stem Cells, 2019-2030 (USD Million)
  • Figure 13.40. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Cell, 2019-2030 (Million Units)
  • Figure 13.41. Novel Cell Sorting Products and Solutions Market for Animal Cells, 2019-2030 (Million Units)
  • Figure 13.42. Novel Cell Sorting Products and Solutions Market for Cancer Cells, 2019-2030 (Million Units)
  • Figure 13.43. Novel Cell Sorting Products and Solutions Market for Immune Cells, 2019-2030 (Million Units)
  • Figure 13.44. Novel Cell Sorting Products and Solutions Market for Microbial Cells, 2019-2030 (Million Units)
  • Figure 13.45. Novel Cell Sorting Products and Solutions Market for Red Blood Cells / Platelets, 2019-2030 (Million Units)
  • Figure 13.46. Novel Cell Sorting Products and Solutions Market for Stem Cells, 2019-2030 (Million Units)
  • Figure 13.47. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Geography, 2019-2030 (USD Million)
  • Figure 13.48. Novel Cell Sorting Products and Solutions Market in North America, 2019-2030 (USD Million)
  • Figure 13.49. Novel Cell Sorting Products and Solutions Market in Europe, 2019-2030 (USD Million)
  • Figure 13.50. Novel Cell Sorting Products and Solutions Market in Asia-Pacific, 2019-2030 (USD Million)
  • Figure 13.51. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Geography, 2019-2030 (Million Units)
  • Figure 13.52. Novel Cell Sorting Products and Solutions Market in North America, 2019-2030 (Million Units)
  • Figure 13.53. Novel Cell Sorting Products and Solutions Market in Europe, 2019-2030 (Million Units)
  • Figure 13.54. Novel Cell Sorting Products and Solutions Market in Asia-Pacific, 2019-2030 (Million Units)
  • Figure 13.55. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Research Studies, 2019-2030 (USD Million)
  • Figure 13.56. Buoyancy-activated Cell Sorters Market for Research Studies, 2019-2030 (USD Million)
  • Figure 13.57. Buoyancy-activated Consumables and Isolation Kits Market for Research Studies, 2019-2030 (USD Million)
  • Figure 13.58. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Research Studies, 2019-2030 (USD Million)
  • Figure 13.59. Magnetic Levitation-based Cell Sorters Market for Research Studies, 2019-2030 (USD Million)
  • Figure 13.60. Magnetic Levitation-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (USD Million)
  • Figure 13.61. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Research Studies, 2019-2030 (USD Million)
  • Figure 13.62. Microfluidics-based Cell Sorters Market for Research Studies, 2019-2030 (USD Million)
  • Figure 13.63. Microfluidics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (USD Million)
  • Figure 13.64. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Research Studies, 2019-2030 (USD Million)
  • Figure 13.65. Optoelectronics-based Cell Sorters Market for Research Studies, 2019-2030 (USD Million)
  • Figure 13.66. Optoelectronics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (USD Million)
  • Figure 13.67. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Research Studies, 2019-2030 (USD Million)
  • Figure 13.68. Other Advanced Technologies-based Cell Sorters Market for Research Studies, 2019-2030 (USD Million)
  • Figure 13.69. Other Advanced Technologies-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (USD Million)
  • Figure 13.70. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Research Studies, 2019-2030 (Million Units)
  • Figure 13.71. Buoyancy-activated Cell Sorters Market for Research Studies, 2019-2030 (Million Units)
  • Figure 13.72. Buoyancy-activated Consumables and Isolation Kits Market for Research Studies, 2019-2030 (Million Units)
  • Figure 13.73. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Research Studies, 2019-2030 (Million Units)
  • Figure 13.74. Magnetic Levitation-based Cell Sorters Market for Research Studies, 2019-2030 (Million Units)
  • Figure 13.75. Magnetic Levitation-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (Million Units)
  • Figure 13.76. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Research Studies, 2019-2030 (Million Units)
  • Figure 13.77. Microfluidics-based Cell Sorters Market for Research Studies, 2019-2030 (Million Units)
  • Figure 13.78. Microfluidics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (Million Units)
  • Figure 13.79. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Research Studies, 2019-2030 (Million Units)
  • Figure 13.80. Optoelectronics-based Cell Sorters Market for Research Studies, 2019-2030 (Million Units)
  • Figure 13.81. Optoelectronics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (Million Units)
  • Figure 13.82. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Research Studies, 2019-2030 (Million Units)
  • Figure 13.83. Other Advanced Technologies-based Cell Sorters Market for Research Studies, 2019-2030 (Million Units)
  • Figure 13.84. Other Advanced Technologies-based Consumables and Isolation Kits Market for Research Studies, 2019-2030 (Million Units)
  • Figure 13.85. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
  • Figure 13.86. Buoyancy-activated Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
  • Figure 13.87. Buoyancy-activated Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
  • Figure 13.88. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
  • Figure 13.89. Magnetic Levitation-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
  • Figure 13.90. Magnetic Levitation-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
  • Figure 13.91. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
  • Figure 13.92. Microfluidics-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
  • Figure 13.93. Microfluidics-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
  • Figure 13.94. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
  • Figure 13.95. Optoelectronics-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
  • Figure 13.96. Optoelectronics-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
  • Figure 13.97. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
  • Figure 13.98. Other Advanced Technologies-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
  • Figure 13.99. Other Advanced Technologies-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (USD Million)
  • Figure 14.100. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
  • Figure 14.101. Buoyancy-activated Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
  • Figure 14.102. Buoyancy-activated Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
  • Figure 14.103. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
  • Figure 14.104. Magnetic Levitation-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
  • Figure 14.105. Magnetic Levitation-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
  • Figure 14.106. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
  • Figure 14.107. Microfluidics-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
  • Figure 14.108. Microfluidics-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
  • Figure 14.109. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
  • Figure 14.110. Optoelectronics-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
  • Figure 14.111. Optoelectronics-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
  • Figure 14.112. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
  • Figure 14.113. Other Advanced Technologies-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
  • Figure 14.114. Other Advanced Technologies-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
  • Figure 14.115. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for In vitro Fertilization, 2019-2030 (USD Million)
  • Figure 14.116. Buoyancy-activated Cell Sorters Market for In vitro Fertilization, 2019-2030 (USD Million)
  • Figure 14.117. Buoyancy-activated Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (USD Million)
  • Figure 14.118. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for In vitro Fertilization, 2019-2030 (USD Million)
  • Figure 14.119. Magnetic Levitation-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (USD Million)
  • Figure 14.120. Magnetic Levitation-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (USD Million)
  • Figure 14.121. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for In vitro Fertilization, 2019-2030 (USD Million)
  • Figure 14.122. Microfluidics-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (USD Million)
  • Figure 14.123. Microfluidics-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (USD Million)
  • Figure 14.124. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for In vitro Fertilization, 2019-2030 (USD Million)
  • Figure 14.125. Optoelectronics-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (USD Million)
  • Figure 14.126. Optoelectronics-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (USD Million)
  • Figure 14.127. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for In vitro Fertilization, 2019-2030 (USD Million)
  • Figure 14.128. Other Advanced Technologies-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (USD Million)
  • Figure 14.129. Other Advanced Technologies-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (USD Million)
  • Figure 14.130. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for In vitro Fertilization, 2019-2030 (Million Units)
  • Figure 14.131. Buoyancy-activated Cell Sorters Market for In vitro Fertilization, 2019-2030 (Million Units)
  • Figure 14.132. Buoyancy-activated Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (Million Units)
  • Figure 14.133. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for In vitro Fertilization, 2019-2030 (Million Units)
  • Figure 14.134. Magnetic Levitation-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (Million Units)
  • Figure 14.135. Magnetic Levitation-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (Million Units)
  • Figure 14.136. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for In vitro Fertilization, 2019-2030 (Million Units)
  • Figure 14.137. Microfluidics-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (Million Units)
  • Figure 14.138. Microfluidics-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (Million Units)
  • Figure 14.139. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for In vitro Fertilization, 2019-2030 (Million Units)
  • Figure 14.140. Optoelectronics-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (Million Units)
  • Figure 14.141. Optoelectronics-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (Million Units)
  • Figure 14.142. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for In vitro Fertilization, 2019-2030 (Million Units)
  • Figure 14.143. Other Advanced Technologies-based Cell Sorters Market for In vitro Fertilization, 2019-2030 (Million Units)
  • Figure 14.144. Other Advanced Technologies-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030 (Million Units)
  • Figure 14.145. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
  • Figure 14.146. Buoyancy-activated Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
  • Figure 14.147. Buoyancy-activated Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
  • Figure 14.148. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
  • Figure 14.149. Magnetic Levitation-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
  • Figure 14.150. Magnetic Levitation-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
  • Figure 14.151. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
  • Figure 14.152. Microfluidics-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
  • Figure 14.153. Microfluidics-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
  • Figure 14.154. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
  • Figure 14.155. Optoelectronics-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
  • Figure 14.156. Optoelectronics-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
  • Figure 14.157. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
  • Figure 14.158. Other Advanced Technologies-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
  • Figure 14.159. Other Advanced Technologies-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (USD Million)
  • Figure 14.160. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
  • Figure 14.161. Buoyancy-activated Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
  • Figure 14.162. Buoyancy-activated Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
  • Figure 14.163. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
  • Figure 14.164. Magnetic Levitation-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
  • Figure 14.165. Magnetic Levitation-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
  • Figure 14.166. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
  • Figure 14.167. Microfluidics-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
  • Figure 14.168. Microfluidics-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
  • Figure 14.169. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
  • Figure 14.170. Optoelectronics-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
  • Figure 14.171. Optoelectronics-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
  • Figure 14.172. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
  • Figure 14.173. Other Advanced Technologies-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
  • Figure 14.174. Other Advanced Technologies-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
  • Figure 14.175. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Cell-based Therapeutics, 2019-2030 (USD Million)
  • Figure 14.176. Buoyancy-activated Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (USD Million)
  • Figure 14.177. Buoyancy-activated Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (USD Million)
  • Figure 14.178. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (USD Million)
  • Figure 14.179. Magnetic Levitation-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (USD Million)
  • Figure 14.180. Magnetic Levitation-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (USD Million)
  • Figure 14.181. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (USD Million)
  • Figure 14.182. Microfluidics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (USD Million)
  • Figure 14.183. Microfluidics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (USD Million)
  • Figure 14.184. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (USD Million)
  • Figure 14.185. Optoelectronics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (USD Million)
  • Figure 14.186. Optoelectronics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (USD Million)
  • Figure 14.187. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (USD Million)
  • Figure 14.188. Other Advanced Technologies-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (USD Million)
  • Figure 14.189. Other Advanced Technologies-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (USD Million)
  • Figure 14.190. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Cell-based Therapeutics, 2019-2030 (Million Units)
  • Figure 14.191. Buoyancy-activated Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (Million Units)
  • Figure 14.192. Buoyancy-activated Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (Million Units)
  • Figure 14.193. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (Million Units)
  • Figure 14.194. Magnetic Levitation-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (Million Units)
  • Figure 14.195. Magnetic Levitation-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (Million Units)
  • Figure 14.196. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (Million Units)
  • Figure 14.197. Microfluidics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (Million Units)
  • Figure 14.198. Microfluidics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (Million Units)
  • Figure 14.199. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (Million Units)
  • Figure 14.200. Optoelectronics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (Million Units)
  • Figure 14.201. Optoelectronics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (Million Units)
  • Figure 14.202. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Cell-based Therapeutics, 2019-2030 (Million Units)
  • Figure 14.203. Other Advanced Technologies-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030 (Million Units)
  • Figure 14.204. Other Advanced Technologies-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030 (Million Units)

List of Tables

  • Table 3.1. Conventional Flow Cytometers
  • Table 3.2. Microfluidics-based Cell Sorting Technologies
  • Table 4.1. Novel Cell Sorting Products and Solutions: Information on Type of Product, Cell Sorting Technology and Type of Cell
  • Table 4.2. Novel Cell Sorting Products and Solutions: Information on Cell Separation Approach, Basis for Separation and End Use / Application
  • Table 4.3. Novel Cell Sorting Products and Solutions: Information on Key Specifications
  • Table 4.4. Novel Cell Sorting Products and Solutions: Developer Overview
  • Table 5.1. Competitiveness Analysis of Small-sized Novel Cell Sorting Products and Solutions Providers
  • Table 5.2. Competitiveness Analysis of Mid-sized Novel Cell Sorting Products and Solutions Providers
  • Table 5.3. Competitiveness Analysis of Large-sized Novel Cell Sorting Products and Solutions Providers
  • Table 6.1. NanoCellect Biomedical: Key Highlights
  • Table 6.2. NanoCellect Biomedical: Funding Instances
  • Table 6.3. NanoCellect Biomedical: Key Characteristics of WOLF® Cell Sorter and N1® Single Cell Dispenser
  • Table 6.4. NanoCellect Biomedical: Recent Developments and Future Outlook
  • Table 6.5. Innovative Biochips: Key Highlights
  • Table 6.6. Innovative Biochips: Funding Instances
  • Table 6.7. Innovative Biochips: Key Characteristics of SMART ALIQUOTOR, SMART ALIQUOTOR COMPACT EDITION and SMART ALIQUOTOR EXTENDED EDITION
  • Table 6.8. Recent Developments and Future Outlook
  • Table 6.9. Cesca Therapeutics: Key Highlights
  • Table 6.10. Cesca Therapeutics: Funding Instances
  • Table 6.11. Cesca Therapeutics: Key Characteristics of AUTOXPRESS®, CAR-TXPRESS™ and CELLXPRESS™
  • Table 6.12. Recent Developments and Future Outlook
  • Table 6.13. Fluidigm: Key Highlights
  • Table 6.14. Fluidigm: Funding Instances
  • Table 6.15. Fluidigm: Key Characteristics of C1™ System
  • Table 6.16. Fluidigm: Recent Developments and Future Outlook
  • Table 6.17. LumaCyte: Key Highlights
  • Table 6.18. LumaCyte: Funding Instances
  • Table 6.19. LumaCyte: Key Characteristics of Radiance™
  • Table 6.20. LumaCyte: Recent Developments and Future Outlook
  • Table 6.21. Union Biometrica: Key Highlights
  • Table 6.22. Union Biometrica: Key Characteristics of COPAS™ FP and BioSorter®
  • Table 6.23. Union Biometrica: Recent Developments and Future Outlook
  • Table 6.24. LevitasBio: Key Highlights
  • Table 6.25. LevitasBio: Funding Instances
  • Table 6.26. LevitasBio: Key Characteristics of LeviCell System
  • Table 6.27. LevitasBio: Recent Developments and Future Outlook
  • Table 6.28. RareCyte®: Key Highlights
  • Table 6.29. RareCyte®: Funding Instances
  • Table 6.30. RareCyte®: Key Characteristics of AccuCyte® Sample Preparation System
  • Table 6.31. RareCyte®: Recent Developments and Future Outlook
  • Table 6.32. Cytonome: Key Highlights
  • Table 6.33. Cytonome: Key Characteristics of Cytonome Viva™, Cytonome Hydris™, Cytonome GigaSort™
  • Table 6.34. Cytonome: Recent Developments and Future Outlook
  • Table 6.35. Namocell: Key Highlights
  • Table 6.36. Namocell: Funding Instances
  • Table 6.37. Namocell: Key Characteristics of Namo™ Single Cell Dispenser and Hana™ Single Cell Dispenser
  • Table 6.38. Namocell: Recent Developments and Future Outlook
  • Table 7.1. STEMCELL Technologies: Key Highlights
  • Table 7.2. STEMCELL Technologies: Funding Instances
  • Table 7.3. STEMCELL Technologies: Product Portfolio
  • Table 7.4. STEMCELL Technologies: Recent Developments and Future Outlook
  • Table 7.5. Akadeum Life Sciences: Key Highlights
  • Table 7.6. Akadeum Life Sciences: Funding Instances
  • Table 7.7. Akadeum Life Sciences: Product Portfolio
  • Table 7.8. Akadeum Life Sciences: Recent Developments and Future Outlook
  • Table 7.3. QIAGEN: Key Highlights
  • Table 7.10. QIAGEN: Funding Instances
  • Table 7.11. QIAGEN: Product Portfolio
  • Table 7.12. QIAGEN: Recent Developments and Future Outlook
  • Table 7.13. ScreenCell: Key Highlights
  • Table 7.14. ScreenCell: Product Portfolio
  • Table 7.15. ScreenCell: Recent Developments and Future Outlook
  • Table 7.16. RareCyte®: Product Portfolio
  • Table 8.1. Patent Analysis: CPC Symbol Definitions
  • Table 8.2. Patent Analysis: Most Popular CPC Symbols
  • Table 8.3. Patent Analysis: List of Top CPC Symbols
  • Table 8.4. Novel Cell Sorting Products and Solutions: Summary of Patent Benchmarking Analysis
  • Table 8.5. Novel Cell Sorting Products and Solutions: Categorizations based on Weighted Valuation Scores
  • Table 8.6. Leading Patents: Distribution by Relative Valuation
  • Table 8.7. Leading Patents: Distribution by Number of Citations
  • Table 10.1. Novel Cell Sorting Products and Solutions: List of Partnerships, 2014-Q1 2019
  • Table 10.2. Most Active Players: Geographical Distribution by Number of Partnerships
  • Table 11.1. Novel Cell Sorting Products and Solutions: List of Funding Instances, 2014-Q1 2019
  • Table 11.2. Novel Cell Sorting Products and Solutions: Summary of Investments
  • Table 14.1. Akadeum Life Sciences: Key Highlights
  • Table 14.2. LumaCyte: Key Highlights
  • Table 14.3. Namocell: Key Highlights
  • Table 15.1. Novel Cell Sorting Products and Solutions: Key Takeaways
  • Table 16.1. Novel Cell Sorting Products and Solutions: Distribution by Type of Product
  • Table 16.2. Novel Cell Sorting Products and Solutions: Distribution by Cell Sorting Technology
  • Table 16.3. Novel Cell Sorting Products and Solutions: Distribution by Type of Cell
  • Table 16.4. Novel Cell Sorting Products and Solutions: Distribution by Cell Separation Approach
  • Table 16.5. Novel Cell Sorting Products and Solutions: Distribution by Basis for Separation
  • Table 16.6. Novel Cell Sorting Products and Solutions: Distribution by End Use / Application
  • Table 16.7. Novel Cell Sorting Products and Solutions: Distribution of Industry Players by Year of Establishment
  • Table 16.8. Novel Cell Sorting Products and Solutions: Distribution of Industry Players by Geographical Location
  • Table 16.9. Novel Cell Sorting Products and Solutions: Distribution of Industry Players by Company Size
  • Table 16.10. Novel Cell Sorting Products and Solutions: Distribution of Industry Players by Type of Offering
  • Table 16.11. Leading Developers: Distribution by Number of Products
  • Table 16.12. Competitiveness Analysis of Small-sized Novel Cell Sorting Products and Solutions Providers
  • Table 16.13. Competitiveness Analysis of Mid-sized Novel Cell Sorting Products and Solutions Providers
  • Table 16.14. Competitiveness Analysis of Large Novel Cell Sorting Products and Solutions Providers
  • Table 16.15. Patent Analysis: Distribution by Type
  • Table 16.16. Patent Analysis: Cumulative Year-wise Trend, 2014-2018
  • Table 16.17. Patent Analysis: Distribution by Geographical Location
  • Table 16.18. Patent Analysis: Distribution by CPC Symbols (Top 20)
  • Table 16.19. Most Active Industry Players: Distribution by Number of Patents
  • Table 16.20. Most Active Non-Industry Players: Distribution by Number of Patents
  • Table 16.21. Patent Analysis: Benchmarking by Patent Characteristics
  • Table 16.22. Patent Analysis: Benchmarking by Number of Patents Published across Different Geographies
  • Table 16.23. Patent Analysis: Benchmarking by Number of International Patents
  • Table 16.24. Patent Analysis: Distribution by Patent Age, 2014-2018
  • Table 16.25. Patent Analysis: Distribution by Geography and Year of Publication, 2014-2018
  • Table 16.26. Patent Analysis: Distribution by Relative Valuation
  • Table 16.27. Publication Analysis: Cumulative Year-wise Trend, 2014-2018
  • Table 16.28. Publication Analysis: Distribution by Cell Sorting Technology
  • Table 16.29. Publication Analysis: Distribution by End Use / Application Area
  • Table 16.30. Publication Analysis: Distribution by Type of Cell
  • Table 16.31. Publication Analysis: Distribution by Target Disease Indication
  • Table 16.32. Publication Analysis: Distribution by Type of Organization Involved
  • Table 16.33. Most Active Players: Distribution by Number of Publications
  • Table 16.34. Most Active Players: Geographical Distribution by Number of Publications
  • Table 16.35. Key Journals: Distribution by Number of Publications
  • Table 16.36. Partnerships and Collaborations: Cumulative Year-wise Trend, 2014-Q1 2019
  • Table 16.37. Partnerships and Collaborations: Distribution by Type of Partnership
  • Table 16.38. Partnerships and Collaborations: Year-wise Trend by Type of Partnership
  • Table 16.39. Partnerships and Collaborations: Distribution by Partner's Focus Area
  • Table 16.40. Partnerships and Collaborations: Distribution by Cell Sorting Technology
  • Table 16.41. Partnerships and Collaborations: Year-wise Trend by Cell Sorting Technology
  • Table 16.42. Most Active Players: Distribution by Number of Partnerships
  • Table 16.43. Most Active Players: Geographical Distribution by Number of Partnerships
  • Table 16.44. Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
  • Table 16.45. Funding and Investments: Distribution of Industry Players by Year of Establishment and Type of Funding, 2014-Q1 2019
  • Table 16.46. Funding and Investments: Distribution of Amount Invested by Focus Area and Type of Funding, 2014-Q1 2019
  • Table 16.47. Funding and Investments: Cumulative Year-wise Trend, 2014-Q1 2019
  • Table 16.48. Funding and Investments: Cumulative Amount Invested by Year, 2014-Q1 2019 (USD Million)
  • Table 16.49. Funding and Investments: Distribution by Type of Funding
  • Table 16.50. Funding and Investments: Distribution by Amount Invested and Type of Funding (USD Million)
  • Table 16.51. Popular Cell Sorting Technologies: Distribution by Number of Funding Instances
  • Table 16.52. Popular Cell Sorting Technologies: Distribution by Amount Invested (USD Million)
  • Table 16.53. Funding and Investments: Year-wise Trend of Amount Invested across Different Cell Sorting Technologies, 2014-Q1 2019 (USD Million)
  • Table 16.54. Most Active Players: Distribution by Number of Instances
  • Table 16.55. Most Active Players: Distribution by Capital Amount Raised (USD Million)
  • Table 16.56. Most Active Investors: Distribution by Number of Instances
  • Table 16.57. Funding and Investments: Geographical Distribution by Amount Invested (USD Million)
  • Table 16.58. Global Demand for Novel Cell Sorting Products and Solutions, 2019-2030 (Million Units)
  • Table 16.59. Global Demand for Novel Cell Sorting Products and Solutions for Research Studies, 2019-2030 (Million Units)
  • Table 16.60. Global Demand for Novel Cell Sorting Products and Solutions for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
  • Table 16.61. Global Demand for Novel Cell Sorting Products and Solutions for In vitro Fertilization, 2019-2030 (Million Units)
  • Table 16.62. Global Demand for Novel Cell Sorting Products and Solutions for Non-Invasive Prenatal Diagnostics, 2019-2030 (Million Units)
  • Table 16.63. Global Demand for Novel Cell Sorting Products and Solutions for Cell-based Therapeutics, 2019-2030 (Million Units)
  • Table 16.64. Demand for Novel Cell Sorting Products and Solutions in North America, 2019-2030 (Million Units)
  • Table 16.65. Demand for Novel Cell Sorting Products and Solutions in North America for Research Studies, 2019-2030 (Million Units)
  • Table 16.66. Demand for Novel Cell Sorting Products and Solutions in North America for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
  • Table 16.67. Demand for Novel Cell Sorting Products and Solutions in North America for In vitro Fertilization, 2019-2030 (Million Units)
  • Table 16.68. Demand for Novel Cell Sorting Products and Solutions in North America for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
  • Table 16.69. Demand for Novel Cell Sorting Products and Solutions in North America for Cell-based Therapeutics, 2019-2030 (Million Units)
  • Table 16.70. Demand for Novel Cell Sorting Products and Solutions in Europe, 2019-2030 (Million Units)
  • Table 16.71. Demand for Novel Cell Sorting Products and Solutions in Europe for Research Studies, 2019-2030 (Million Units)
  • Table 16.72. Demand for Novel Cell Sorting Products and Solutions in Europe for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
  • Table 16.73. Demand for Novel Cell Sorting Products and Solutions in Europe for In vitro Fertilization, 2019-2030 (Million Units)
  • Table 16.74. Demand for Novel Cell Sorting Products and Solutions in Europe for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
  • Table 16.75. Demand for Novel Cell Sorting Products and Solutions in Europe for Cell-based Therapeutics, 2019-2030 (Million Units)
  • Table 16.76. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific, 2019-2030 (Million Units)
  • Table 16.77. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Research Studies, 2019-2030 (Million Units)
  • Table 16.78. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Circulating Tumor Cell Detection, 2019-2030 (Million Units)
  • Table 16.79. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for In vitro Fertilization, 2019-2030 (Million Units)
  • Table 16.80. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Non-Invasive Prenatal Diagnosis, 2019-2030 (Million Units)
  • Table 16.81. Demand for Novel Cell Sorting Products and Solutions in Asia-Pacific for Cell-based Therapeutics, 2019-2030 (Million Units)
  • Table 16.82. Overall Novel Cell Sorting Products and Solutions Market, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.83. Overall Novel Cell Sorting Products and Solutions Market, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.84. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Offering, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.85. Novel Cell Sorting Products and Solutions Market for Cell Sorters, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.86. Novel Cell Sorting Products and Solutions Market for Consumables and Isolation Kits, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.87. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Offering, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.88. Novel Cell Sorting Products and Solutions Market for Cell Sorters, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.89. Novel Cell Sorting Products and Solutions Market for Consumables and Isolation Kits, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.90. Overall Novel Cell Sorting Products and Solutions Market: Distribution by End Use / Application, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.91. Novel Cell Sorting Products and Solutions Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.92. Novel Cell Sorting Products and Solutions Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.93. Novel Cell Sorting Products and Solutions Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.94. Novel Cell Sorting Products and Solutions Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.95. Novel Cell Sorting Products and Solutions Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.96. Overall Novel Cell Products and Solutions Market: Distribution by End Use / Application, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.97. Novel Cell Sorting Products and Solutions Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.98. Novel Cell Sorting Products and Solutions Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.99. Novel Cell Sorting Products and Solutions Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.100. Novel Cell Sorting Products and Solutions Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.101. Novel Cell Sorting Products and Solutions Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.102. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Cell Sorting Technology, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.103. Novel Cell Sorting Products and Solutions Market for Buoyancy-activated, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.104. Novel Cell Sorting Products and Solutions Market for Magnetic Levitation, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.105. Novel Cell Sorting Products and Solutions Market for Microfluidics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.106. Novel Cell Sorting Products and Solutions Market for Optoelectronics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.107. Novel Cell Sorting Products and Solutions Market for Other Advanced Technologies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.108. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Cell Sorting Technology, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.109. Novel Cell Sorting Products and Solutions Market for Buoyancy-activated, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.110. Novel Cell Sorting Products and Solutions Market for Magnetic Levitation, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.111. Novel Cell Sorting Products and Solutions Market for Microfluidics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.112. Novel Cell Sorting Products and Solutions Market for Optoelectronics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.113. Novel Cell Sorting Products and Solutions Market for Other Advanced Technologies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.114. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Cell, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.115. Novel Cell Sorting Products and Solutions Market for Animal Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.116. Novel Cell Sorting Products and Solutions Market for Cancer Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.117. Novel Cell Sorting Products and Solutions Market for Immune Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.118. Novel Cell Sorting Products and Solutions Market for Microbial Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.119. Novel Cell Sorting Products and Solutions Market for Red Blood Cells / Platelets, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.120. Novel Cell Sorting Products and Solutions Market for Stem Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.121. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Type of Cell, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.122. Novel Cell Sorting Products and Solutions Market for Animal Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.123. Novel Cell Sorting Products and Solutions Market for Cancer Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.124. Novel Cell Sorting Products and Solutions Market for Immune Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.125. Novel Cell Sorting Products and Solutions Market for Microbial Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.126. Novel Cell Sorting Products and Solutions Market for Red Blood Cells / Platelets, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.127. Novel Cell Sorting Products and Solutions Market for Stem Cells, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.128. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Geography, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.129. Novel Cell Sorting Products and Solutions Market in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.130. Novel Cell Sorting Products and Solutions Market in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.131. Novel Cell Sorting Products and Solutions Market in Asia-Pacific, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.132. Overall Novel Cell Sorting Products and Solutions Market: Distribution by Geography, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.133. Novel Cell Sorting Products and Solutions Market in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.134. Novel Cell Sorting Products and Solutions Market in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.135. Novel Cell Sorting Products and Solutions Market in Asia-Pacific, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.136. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.137. Buoyancy-activated Cell Sorters Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.138. Buoyancy-activated Consumables and Isolation Kits Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.139. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.140. Magnetic Levitation-based Cell Sorters Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.141. Magnetic Levitation-based Consumables and Isolation Kits Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.142. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.143. Microfluidics-based Cell Sorters Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.144. Microfluidics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.145. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.146. Optoelectronics-based Cell Sorters Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.147. Optoelectronics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.148. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.149. Other Advanced Technologies-based Cell Sorters Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.150. Other Advanced Technologies-based Consumables and Isolation Kits Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.151. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.152. Buoyancy-activated Cell Sorters Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.153. Buoyancy-activated Consumables and Isolation Kits Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.154. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.155. Magnetic Levitation-based Cell Sorters Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.156. Magnetic Levitation-based Consumables and Isolation Kits Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.157. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.158. Microfluidics-based Cell Sorters Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.159. Microfluidics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.160. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.161. Optoelectronics-based Cell Sorters Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.162. Optoelectronics-based Consumables and Isolation Kits Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.163. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.164. Other Advanced Technologies-based Cell Sorters Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.165. Other Advanced Technologies-based Consumables and Isolation Kits Market for Research Studies, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.166. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.167. Buoyancy-activated Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.168. Buoyancy-activated Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.169. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.170. Magnetic Levitation-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.171. Magnetic Levitation-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.172. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.173. Microfluidics-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.174. Microfluidics-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.175. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.176. Optoelectronics-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.177. Optoelectronics-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.178. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.179. Other Advanced Technologies-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.180. Other Advanced Technologies-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.181. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.182. Buoyancy-activated Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.183. Buoyancy-activated Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.184. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.185. Magnetic Levitation-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.186. Magnetic Levitation-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.187. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.188. Microfluidics-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.189. Microfluidics-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.190. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.191. Optoelectronics-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.192. Optoelectronics-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.193. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.194. Other Advanced Technologies-based Cell Sorters Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.195. Other Advanced Technologies-based Consumables and Isolation Kits Market for Circulating Tumor Cell Detection, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.196. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.197. Buoyancy-activated Cell Sorters Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.198. Buoyancy-activated Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.199. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.200. Magnetic Levitation-based Cell Sorters Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.201. Magnetic Levitation-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.202. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.203. Microfluidics-based Cell Sorters Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.204. Microfluidics-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.205. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.206. Optoelectronics-based Cell Sorters Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.207. Optoelectronics-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.208. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.209. Other Advanced Technologies-based Cell Sorters Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.210. Other Advanced Technologies-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.211. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.212. Buoyancy-activated Cell Sorters Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.213. Buoyancy-activated Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.214. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.215. Magnetic Levitation-based Cell Sorters Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.216. Magnetic Levitation-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.217. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.218. Microfluidics-based Cell Sorters Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.219. Microfluidics-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.220. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.221. Optoelectronics-based Cell Sorters Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.222. Optoelectronics-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.223. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.224. Other Advanced Technologies-based Cell Sorters Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.225. Other Advanced Technologies-based Consumables and Isolation Kits Market for In vitro Fertilization, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.226. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.227. Buoyancy-activated Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.228. Buoyancy-activated Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.229. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.230. Magnetic Levitation-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.231. Magnetic Levitation-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.232. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.233. Microfluidics-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.234. Microfluidics-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.235. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.236. Optoelectronics-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.237. Optoelectronics-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.238. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.239. Other Advanced Technologies-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.240. Other Advanced Technologies-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.241. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.242. Buoyancy-activated Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.243. Buoyancy-activated Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.244. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.245. Magnetic Levitation-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.246. Magnetic Levitation-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.247. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.248. Microfluidics-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.249. Microfluidics-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.250. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.251. Optoelectronics-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.252. Optoelectronics-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.253. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.254. Other Advanced Technologies-based Cell Sorters Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.255. Other Advanced Technologies-based Consumables and Isolation Kits Market for Non-Invasive Prenatal Diagnosis, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.256. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.257. Buoyancy-activated Cell Sorters Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.258. Buoyancy-activated Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.259. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.260. Magnetic Levitation-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.261. Magnetic Levitation-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.262. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.263. Microfluidics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.264. Microfluidics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.265. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.266. Optoelectronics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.267. Optoelectronics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.268. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.269. Other Advanced Technologies-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.270. Other Advanced Technologies-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 16.271. Novel Cell Sorting Market for Buoyancy-activated Products and Solutions for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.272. Buoyancy-activated Cell Sorters Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.273. Buoyancy-activated Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.274. Novel Cell Sorting Market for Magnetic Levitation-based Products and Solutions for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.275. Magnetic Levitation-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.276. Magnetic Levitation-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.277. Novel Cell Sorting Market for Microfluidics-based Products and Solutions for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.278. Microfluidics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.279. Microfluidics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.280. Novel Cell Sorting Market for Optoelectronics-based Products and Solutions for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.281. Optoelectronics-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.282. Optoelectronics-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.283. Novel Cell Sorting Market for Other Advanced Technologies-based Products and Solutions for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.284. Other Advanced Technologies-based Cell Sorters Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)
  • Table 16.285. Other Advanced Technologies-based Consumables and Isolation Kits Market for Cell-based Therapeutics, 2019-2030: Conservative, Base and Optimistic Scenarios (Million Units)

List of Companies

The following companies / institutes / government bodies and organizations have been mentioned in this report.

  • 1087systems
  • 48Hour Discovery
  • 5AM Ventures
  • Abbott
  • AbbVie
  • Academia Sinica
  • Academic Medical Centre
  • Academy of Military Medical Sciences
  • Accelerate Diagnostics
  • ACEA Biosciences
  • AcouSort
  • Active Biotech
  • Adaptive Biotechnologies
  • Adelaide Research & Innovation
  • AdnaGen
  • ADS BIOTEC
  • Advanced Virus Detection Technologies Interest Group
  • Aegea Biotechnologies
  • Aenitis Technologies
  • Agency for Science, Technology and Research
  • Agilent Technologies
  • AIM Group International
  • AIMM Therapeutics
  • Akadeum Life Sciences
  • Albert Einstein College of Medicine
  • Alder BioPharmaceuticalss
  • Alexion Pharmaceuticals
  • Alkem Laboratories
  • Amazentis
  • Ambergen
  • American Institute of Health
  • Amgen
  • AnaptysBio
  • Ancera
  • Angel HQ
  • Angel Round Capital Fund
  • ANGLE
  • Ann & Robert H Lurie Children's Hospital of Chicago
  • ANSYS
  • Anzu Partners
  • ApoCell
  • Argonaut Manufacturing Services
  • arivis
  • Artiman Ventures
  • Ascent Bio-Nano Technologies
  • Ascus Biosciences
  • Astellas Pharma
  • Augusta University
  • Aurora Life Technologies
  • AVIVA Biosciences
  • Barts Cancer Institute
  • Base4 Innovation
  • Bay City Capital
  • Bayer
  • BC Cancer Agency
  • Beckman Coulter
  • Becton Dickinson
  • Beijing Genomics Institute
  • Beth Israel Deaconess Medical Center
  • Betta Pharmaceuticals
  • BGI Group
  • Biocept
  • Bioceptive
  • BioCrine
  • BioFluidica
  • BioInfleXion Point Partners
  • BIOKÉ
  • Biolidics
  • BioMEMS Resource Center
  • BioMimetic Therapeutics
  • Bio-Rad Laboratories
  • BIOSS
  • Bio-Techne
  • BioTheranostics
  • BioView
  • Boehringer Ingelheim
  • Boyalife Group
  • Bpifrance
  • Brigham and Women's Hospital
  • Bristol-Myers Squibb
  • Broad Institute
  • Bucher Biotec
  • C4 Therapeutics
  • California Institute of Technology
  • California NanoSystems Institute
  • Caltag Medsystems
  • Cambridge Consultants
  • Cambridge Enterprise
  • Canary Center at Stanford
  • Cancer Genetics
  • Cancer Institute of Greenville Health System
  • Cancer Metastasis Laboratory, University of Basel
  • Cancer Research UK Manchester Institute
  • CANCER-ID
  • Canon US Life Sciences
  • Capio Biosciences
  • Caris Life Sciences
  • Carnegie Mellon University
  • Case Western Reserve University
  • Catalyst Biosciences
  • Celgene
  • Cell Microsystems
  • Cell Signaling Technology
  • Cell.Copedia
  • Cellaviva
  • CellectCell
  • Cellenion
  • Cellix
  • CellMax Life
  • Celsee
  • Center for Advanced Medical Products
  • Centre Léon Bérard
  • Cephalon
  • Cesca Therapeutics
  • CFD Research
  • Chang Gung Memorial Hospital
  • ChemoCentryx
  • Chinese Academy of Medical Sciences
  • Cincinnati Children's Hospital Medical Center
  • Cipla
  • Clinomics
  • Columbia University
  • Cornell University
  • Corning
  • Creative BioArray
  • Creative Diagnostics
  • CREST
  • CRV International
  • CureGene
  • Cytonome
  • CytoVale
  • Cytovance Biologics
  • Dana-Farber Cancer Institute
  • Danaher
  • DAON BioSciences
  • Decheng Capital
  • Department of Biomedical Engineering, Lund University
  • Detroit Innovate
  • DiaSorin
  • Diffusion Capital Partners
  • Draper Laboratory
  • Duke University
  • eFFECTOR Therapeutics
  • Eisai
  • EKF Diagnostics
  • eLab Ventures
  • Eli Lilly
  • EMV Capital
  • Engender Technologies
  • Enlivex Therapeutics
  • Enterprise Angels
  • Epic Sciences
  • Evercyte
  • EXONBio
  • Fiona Stanley Hospital
  • Five3 Genomics
  • FloDesign Sonics
  • Florida Cancer Specialists and Research Institute
  • Fluidigm
  • France Innovation Scientifique et Transfert
  • French National Center for Scientific Research
  • Fudan University Shanghai Cancer Center
  • FusionX Ventures
  • GE Healthcare
  • GenapSys
  • Genentech
  • General Automation Lab Technologies
  • Genewiz
  • Genial Laboratory Automation
  • Genoa Ventures
  • Georgetown University
  • Georgia Tech Research Institute
  • Gilead Sciences
  • GILUPI
  • Glass Capital Management
  • GlaxoSmithKline
  • Glenmark Pharmaceuticals
  • GOM
  • Grace Bio-Labs
  • Greenwoods Asset Management
  • GRI Bio
  • Guangxi Academy of Sciences
  • Hahn-Schickard
  • Halcyon Biomedical
  • Halozyme Therapeutics
  • Harvard Stem Cell Institute
  • Harvard University
  • Horizon Discovery
  • Hubei Cancer Clinical Study Center
  • Humacyte
  • Humanitas Research Hospital
  • Hunan Agen Medicine Laboratory Technology
  • IBA Lifesciences
  • Icahn School of Medicine
  • ICE Angels
  • iCellate
  • ICREA
  • Ignyta
  • Illumina Ventures
  • IMEC
  • immatics biotechnologies
  • Immunomedics
  • ImmunoQure
  • Inabata
  • Inbiomotion
  • IncellDx
  • IncoCell Tianjin
  • Incyte
  • Inguran
  • Innate Pharma
  • Innovate UK
  • Innovative Biochips
  • Innovative Micro Technology
  • Inova
  • Institute of Cancer Research, London
  • Institute of Organic Chemistry and Biochemistry
  • Instrumentation Laboratory
  • Intrinsic LifeSciences
  • Invention Science Fund
  • Invest Michigan
  • Invetech
  • iPS Portal
  • Janssen Biotech
  • Japan Science and Technology Agency
  • Jiulongpo District People's Hospital
  • Jiva Sciences
  • John Hopkins University
  • John Wayne Cancer Institute
  • Jonsson Comprehensive Cancer Center
  • Karolinska Institute
  • Kataoka
  • Katholieke Universiteit Leuven
  • Keswick Ventures
  • Kiyatec
  • Koek Biotechnology
  • Kymab
  • LabCorp
  • Landos Biopharma
  • Lawson Health Research Institute
  • Leica Biosystems
  • LevitasBio
  • LG Electronics
  • LIDE Biotech
  • Life Technologies
  • Livzon Pharmaceuticals
  • London Business Angels
  • LPATH
  • LumaCyte
  • Luminex
  • LungLifeAI
  • Lupin
  • Mackay Memorial Hospital
  • Massachusetts Institute of Technology
  • Mayo Clinic Foundation
  • MD Anderson Cancer Center
  • MDxK
  • Medigen Biotech
  • MeMed Diagnostics
  • Memorial Sloan Kettering Cancer Center
  • Menarini Silicon Biosystems
  • Merck
  • Metabiota
  • Microbix Biosystems
  • MicroMedicine
  • Middle East Technical University
  • Mikro Biyosistemler
  • Mikro Systems
  • Millennium Pharmaceuticals
  • MilliporeSigma
  • Miltenyi Biotec
  • Morehouse School of Medicine
  • Morphotek
  • Mumbai Angels
  • Namocell
  • NanoCellect Biomedical
  • Nanosphere
  • NanoTag Biotechnologies
  • National Cancer Centre Singapore
  • National Cancer Institute
  • National Center for Emerging and Zoonotic Infectious Diseases
  • National Center for Nanoscience and Technology
  • National Institute for Health Research
  • National Institute for Innovation in Manufacturing Biopharmaceuticals
  • National Institute of Drug Abuse
  • National Institute of General Medical Sciences
  • National Institutes of Health
  • National University Hospital
  • National University of Ireland Galway's Regenerative Medicine Institute
  • National University of Singapore
  • Naval Research Laboratory
  • Nektar Therapeutics
  • NeoDiagnostix
  • NeuroVision Pharma
  • New York Upstate Cord Blood Bank
  • New Zealand Venture Investment Fund
  • Newable Private Investing
  • NextGem
  • Nodality
  • Northeastern University
  • Northwestern University
  • Novartis
  • Novo Nordisk
  • Ohio State Innovation Foundation
  • On-chip Biotechnologies
  • Oregon Health & Science University
  • Organovo
  • Ortho Clinical Diagnostics
  • Orthohealing Center Management
  • Osaka University Venture Capital
  • Owl biomedical
  • OYAK
  • Pacific Biosciences
  • Pacific Channel
  • Packers Sanitation Services
  • Parkwalk Advisors
  • Partec
  • Penn State Research Foundation
  • PerkinElmer
  • Pfizer
  • Pharmaxis
  • Philips
  • Phywe
  • pluriSelect Life Science
  • Purdue Research Foundation
  • Qiagen
  • Quad Technologies
  • Qventures
  • R&D Systems
  • RareCyte
  • Real Tech Fund
  • Regeneron Pharmaceuticals
  • Regionalt Cancercentrum Stockholm-Gotland
  • RIKEN Bioresource Research Center
  • Riverside's Highlander Venture Fund
  • Roche
  • Roswell Park Comprehensive Cancer Center
  • Rowan University
  • Rush University Medical Center
  • Samsung Medical Center
  • Sandoz
  • Sanford Burnham Prebys Medical Discovery Institute
  • Scholar Rock
  • ScreenCell
  • Seoulin Bioscience
  • Sequenom
  • Sequenta
  • Seventure Partners
  • Severance Hospital
  • Shilps Sciences
  • Shriners Hospitals for Children
  • Singapore General Hospital
  • Singapore Immunology Network
  • Singapore-MIT Alliance for Research and Technology
  • Singh Molecular Medicine
  • Singular BIO
  • Sir Charles Gairdner Hospital
  • Siwa Therapeutics
  • Skane University Hospital
  • Sloan Kettering Institute
  • Sony Biotechnology
  • Southampton General Hospital
  • Sphere Fluidics
  • SpheriTech
  • SRI International
  • Stand Up To Cancer
  • Stanford University
  • Stanford Women's Cancer Center
  • StemBioSys
  • Stempeutics Research
  • Stony Brook University
  • Streck
  • Sumitomo Dainippon Pharma
  • Sutter Health
  • Syllogistech
  • SynGen Biotech
  • Syno Capital
  • Sysmex
  • Takeda Pharmaceutical
  • Tan Tock Seng Hospital
  • Targeted Technology Fund
  • Technical University of Denmark
  • Telegraph Hill Partners
  • Texas Stem Cell
  • The Fourth People's Hospital of Chongqing
  • Theranosis Life Sciences
  • Thermo Fisher Scientific
  • ThermoGenesis
  • ThinkCyte
  • Tisch Cancer Institute
  • Tokai Pharmaceuticals
  • TOMY Digital Biology
  • TorpedoDx
  • Tracon Pharmaceuticals
  • Trinity College Dublin
  • TumorGenesis
  • Twist Bioscience
  • Tyme
  • UCB Biopharma
  • UCLA Medical Center
  • Union Biometrica
  • United States Army Medical Research Institute for Infectious Diseases
  • United States Environmental Protection Agency
  • University of British Columbia
  • University of California
  • University of Chicago
  • University of Edinburgh
  • University of Illinois at Urbana-Champaign
  • University of Iowa Research Foundation
  • University of Kansas
  • University of Maryland
  • University of Miami
  • University of Michigan
  • University of Missouri
  • University of North Carolina
  • University of Notre Dame
  • University of Oxford John Radcliffe Hospital
  • University of Pennsylvania
  • University of Southern California Norris Comprehensive Cancer Center
  • University of Texas
  • University of Utah
  • University of Virginia School of Medicine
  • Uppsala University
  • US Department of Veterans Affairs
  • Vancouver Prostate Centre
  • Vanderbilt University
  • Vegenics
  • VentureSouth
  • Vertical Venture Partners
  • Vortex Biosciences
  • VWR
  • Wako Pure Chemical Industries
  • Washington University
  • Wego Medical Systems
  • Whitehead Institute for Biomedical Research
  • Woods Hole Oceanographic Institution
  • Wright State University
  • Xcell Biosciences
  • Yale University
  • Zeiss
  • Zhongnan Hospital of Wuhan University
  • Zomedica Pharmaceuticals
  • Zurich Instruments
  • ZymoGenetics